<?xml version="1.0" encoding="UTF-8"?>
<drug type="small molecule" created="2005-06-13" updated="2020-01-02">
  <drugbank-id primary="true">DB00360</drugbank-id>
  <drugbank-id>APRD01297</drugbank-id>
  <drugbank-id>EXPT00691</drugbank-id>
  <drugbank-id>DB02692</drugbank-id>
  <name>Sapropterin</name>
  <description>Sapropterin (tetrahydrobiopterin or BH4) is a cofactor in the synthesis of nitric oxide. It is also essential in the conversion of phenylalanine to tyrosine by the enzyme phenylalanine-4-hydroxylase; the conversion of tyrosine to L-dopa by the enzyme tyrosine hydroxylase; and conversion of tryptophan to 5-hydroxytryptophan via tryptophan hydroxylase.</description>
  <cas-number>62989-33-7</cas-number>
  <unii>EGX657432I</unii>
  <average-mass>241.2471</average-mass>
  <monoisotopic-mass>241.117489371</monoisotopic-mass>
  <state>solid</state>
  <groups>
    <group>approved</group>
    <group>investigational</group>
  </groups>
  <general-references>
    <articles>
      <article>
        <ref-id>A537</ref-id>
        <pubmed-id>10727395</pubmed-id>
        <citation>Thony B, Auerbach G, Blau N: Tetrahydrobiopterin biosynthesis, regeneration and functions. Biochem J. 2000 Apr 1;347 Pt 1:1-16.</citation>
      </article>
    </articles>
    <textbooks/>
    <links/>
    <attachments/>
  </general-references>
  <synthesis-reference>Steven S. Gross, "Blocking utilization of tetrahydrobiopterin to block induction of nitric oxide synthesis." U.S. Patent US5502050, issued October, 1984.</synthesis-reference>
  <indication>For the treatment of tetrahydrobiopterin (BH4) deficiency.</indication>
  <pharmacodynamics>Tetrahydrobiopterin (BH4) is used to convert several amino acids, including phenylalanine, to other essential molecules in the body including neurotransmitters. Tetrahydrobiopterin deficiency can be caused by mutations in GTP cyclohydrolase 1 (GCH1), 6-pyruvoyl-tetrahydropterin synthase/dimerization cofactor of hepatocyte nuclear factor 1 alpha (PCBD1), 6-pyruvoyltetrahydropterin synthase (PTS), and quinoid dihydropteridine reductase (QDPR) genes. These genes make the enzymes that are critical for producing and recycling tetrahydrobiopterin. If one of the enzymes fails to function correctly because of a gene mutation, little or no tetrahydrobiopterin is produced. As a result, phenylalanine from the diet builds up in the bloodstream and other tissues and can damage nerve cells in the brain. High levels of phenylalanine can result in signs and symptoms ranging from temporary low muscle tone to mental retardation, movement disorders, difficulty swallowing, seizures, behavioral problems, progressive problems with development, and an inability to control body temperature.</pharmacodynamics>
  <mechanism-of-action>Tetrahydrobiopterin (BH4) is a natural co-factor or co-enzyme for phenylalanine-4-hydroxylase (PAH),Tetrahydrobiopterine, and tryptophan-5-hydroxylase. Tetrahydrobiopterin is also a natural co-factor for nitrate oxide synthase. Therefore BH4 is required for the conversion of phenylalanine to tyrosine, for the production of epinephrine (adrenaline) and the synthesis of the monoamine neuro-transmitters, serotonin, dopamine, and norepinephrine (noradrenaline). It is also involved in apoptosis and other cellular events mediated by nitric oxide production. As a coenzyme, BH4 reacts with molecular oxygen to form an active oxygen intermediate that can hydroxylate substrates. In the hydroxylation process, the co-enzyme loses two electrons and is regenerated in vivo in an NADH-dependent reaction. As a co-factor for PAH, tetrahydrobiopterin allows the conversion of phenylalanine to tyrosine and reduces the level of phenylalanine in the bloodstream, thereby reducing the toxic effects of of this amino acid. Normal serum concentrations of phenylalanine are 100 micomolar, while elevated (toxic) levels are typically &gt;1200 micromolar. Individuals with a deficiency in tetrahydrobiopterin are not able to efficiently convert phenylalanine to tyrosine. The excess levels provided by tetrahydrobiopterin supplementation help improve enzyme efficiency. As a co-factor for tyrosine hydroxylase, BH4 facilitates the conversion of tyrosine to L-dopa while as a co-factor for tryptophan hydroxylase, BH4 allows the conversion of tryptophan to 5-hydroxytryptophan, which is then converted to serotonin.</mechanism-of-action>
  <toxicity/>
  <metabolism/>
  <absorption/>
  <half-life/>
  <protein-binding/>
  <route-of-elimination/>
  <volume-of-distribution/>
  <clearance/>
  <classification>
    <description>This compound belongs to the class of organic compounds known as biopterins and derivatives. These are coenzymes containing a 2-amino-pteridine-4-one derivative. They are mainly synthesized in several parts of the body, including the pineal gland.</description>
    <direct-parent>Biopterins and derivatives</direct-parent>
    <kingdom>Organic compounds</kingdom>
    <superclass>Organoheterocyclic compounds</superclass>
    <class>Pteridines and derivatives</class>
    <subclass>Pterins and derivatives</subclass>
    <alternative-parent>1,2-aminoalcohols</alternative-parent>
    <alternative-parent>1,2-diols</alternative-parent>
    <alternative-parent>1,3-aminoalcohols</alternative-parent>
    <alternative-parent>Aminopyrimidines and derivatives</alternative-parent>
    <alternative-parent>Azacyclic compounds</alternative-parent>
    <alternative-parent>Heteroaromatic compounds</alternative-parent>
    <alternative-parent>Hydrocarbon derivatives</alternative-parent>
    <alternative-parent>Organic oxides</alternative-parent>
    <alternative-parent>Organopnictogen compounds</alternative-parent>
    <alternative-parent>Primary amines</alternative-parent>
    <alternative-parent>Pyrimidones</alternative-parent>
    <alternative-parent>Secondary alcohols</alternative-parent>
    <alternative-parent>Secondary alkylarylamines</alternative-parent>
    <alternative-parent>Vinylogous amides</alternative-parent>
    <substituent>1,2-aminoalcohol</substituent>
    <substituent>1,2-diol</substituent>
    <substituent>1,3-aminoalcohol</substituent>
    <substituent>Alcohol</substituent>
    <substituent>Amine</substituent>
    <substituent>Aminopyrimidine</substituent>
    <substituent>Aromatic heteropolycyclic compound</substituent>
    <substituent>Azacycle</substituent>
    <substituent>Biopterin</substituent>
    <substituent>Heteroaromatic compound</substituent>
    <substituent>Hydrocarbon derivative</substituent>
    <substituent>Organic nitrogen compound</substituent>
    <substituent>Organic oxide</substituent>
    <substituent>Organic oxygen compound</substituent>
    <substituent>Organonitrogen compound</substituent>
    <substituent>Organooxygen compound</substituent>
    <substituent>Organopnictogen compound</substituent>
    <substituent>Primary amine</substituent>
    <substituent>Pyrimidine</substituent>
    <substituent>Pyrimidone</substituent>
    <substituent>Secondary alcohol</substituent>
    <substituent>Secondary aliphatic/aromatic amine</substituent>
    <substituent>Secondary amine</substituent>
    <substituent>Vinylogous amide</substituent>
  </classification>
  <salts>
    <salt>
      <drugbank-id primary="true">DBSALT001133</drugbank-id>
      <name>Sapropterin dihydrochloride</name>
      <unii>RG277LF5B3</unii>
      <cas-number>69056-38-8</cas-number>
      <inchikey>RKSUYBCOVNCALL-NTVURLEBSA-N</inchikey>
      <average-mass>314.17</average-mass>
      <monoisotopic-mass>313.0708448</monoisotopic-mass>
    </salt>
  </salts>
  <synonyms>
    <synonym language="english" coder="">(âˆ’)-(6R)-2-amino-6-((1R,2S)-1,2-dihydroxypropyl)-5,6,7,8-tetrahydro-4(3H)-pteridinone</synonym>
    <synonym language="english" coder="">(6R)-L-erythro-5,6,7,8-tetrahydrobiopterin</synonym>
    <synonym language="english" coder="">(6R)-L-erythro-tetrahydrobiopterin</synonym>
    <synonym language="english" coder="">2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydoro-4(1H)-pteridinone</synonym>
    <synonym language="english" coder="">5,6,7,8-Tetrahydrobiopterin</synonym>
    <synonym language="english" coder="">6R-5,6,7,8-tetrahydrobiopterin</synonym>
    <synonym language="english" coder="">6R-BH4</synonym>
    <synonym language="english" coder="">6R-L-5,6,7,8-tetrahydrobiopterin</synonym>
    <synonym language="english" coder="">R-THBP</synonym>
    <synonym language="english" coder="inn">Sapropterin</synonym>
    <synonym language="spanish" coder="inn">Sapropterina</synonym>
    <synonym language="latin" coder="inn">sapropterinum</synonym>
    <synonym language="english" coder="">Tetrahydrobiopterin</synonym>
  </synonyms>
  <products>
    <product>
      <name>Kuvan</name>
      <labeller>BioMarin Pharmaceutical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>68135-300</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-12-14</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength>100 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>NDA022181</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Kuvan</name>
      <labeller>BioMarin Pharmaceutical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>68135-301</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2014-02-21</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Powder, for solution</dosage-form>
      <strength>100 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>NDA205065</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Kuvan</name>
      <labeller>BioMarin Pharmaceutical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>68135-482</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-05-27</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Powder, for solution</dosage-form>
      <strength>500 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>NDA205065</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Kuvan</name>
      <labeller>Biomarin International Limited</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02350580</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-07-05</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength>100 mg</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Kuvan</name>
      <labeller>Biomarin International Limited</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02482207</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Powder</dosage-form>
      <strength>100 mg</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Kuvan</name>
      <labeller>Biomarin International Limited</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02482215</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Powder</dosage-form>
      <strength>500 mg</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Sapropterin Dihydrochloride</name>
      <labeller>Par Pharmaceutical, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>49884-720</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2017-02-02</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength>100 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>ANDA207200</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
  </products>
  <international-brands>
    <international-brand>
      <name>BH4</name>
      <company>Excelsior</company>
    </international-brand>
    <international-brand>
      <name>Biopten</name>
      <company>Daiichi Sankyo</company>
    </international-brand>
  </international-brands>
  <mixtures>
    <mixture>
      <name>Sapropterin Dihydrochloride</name>
      <ingredients>Sapropterin</ingredients>
    </mixture>
    <mixture>
      <name>Kuvan</name>
      <ingredients>Sapropterin</ingredients>
    </mixture>
    <mixture>
      <name>Kuvan</name>
      <ingredients>Sapropterin</ingredients>
    </mixture>
    <mixture>
      <name>Kuvan</name>
      <ingredients>Sapropterin</ingredients>
    </mixture>
    <mixture>
      <name>Kuvan</name>
      <ingredients>Sapropterin</ingredients>
    </mixture>
    <mixture>
      <name>Kuvan</name>
      <ingredients>Sapropterin</ingredients>
    </mixture>
    <mixture>
      <name>Kuvan</name>
      <ingredients>Sapropterin</ingredients>
    </mixture>
  </mixtures>
  <packagers>
    <packager>
      <name>BioMarin Pharmaceuticals Inc.</name>
      <url>http://www.bmrn.com</url>
    </packager>
    <packager>
      <name>Lyne Laboratories Inc.</name>
      <url>http://www.lyne.com</url>
    </packager>
  </packagers>
  <manufacturers>
    <manufacturer generic="false" url="">Biomarin pharmaceutical inc</manufacturer>
  </manufacturers>
  <prices>
    <price>
      <description>Kuvan 100 mg tablet</description>
      <cost currency="USD">36.5</cost>
      <unit>tablet</unit>
    </price>
  </prices>
  <categories>
    <category>
      <category>Alimentary Tract and Metabolism</category>
      <mesh-id/>
    </category>
    <category>
      <category>Amines</category>
      <mesh-id>D000588</mesh-id>
    </category>
    <category>
      <category>Biological Factors</category>
      <mesh-id>D001685</mesh-id>
    </category>
    <category>
      <category>Breast Cancer Resistance Protein Inhibitors</category>
      <mesh-id/>
    </category>
    <category>
      <category>Coenzymes</category>
      <mesh-id>D003067</mesh-id>
    </category>
    <category>
      <category>Dietary Supplements</category>
      <mesh-id>D019587</mesh-id>
    </category>
    <category>
      <category>Enzymes and Coenzymes</category>
      <mesh-id>D045762</mesh-id>
    </category>
    <category>
      <category>Ethylamines</category>
      <mesh-id>D005021</mesh-id>
    </category>
    <category>
      <category>Heterocyclic Compounds, Fused-Ring</category>
      <mesh-id>D000072471</mesh-id>
    </category>
    <category>
      <category>Nitric Oxide Synthase</category>
      <mesh-id>D019001</mesh-id>
    </category>
    <category>
      <category>Other Miscellaneous Therapeutic Agents</category>
      <mesh-id/>
    </category>
    <category>
      <category>P-glycoprotein inhibitors</category>
      <mesh-id/>
    </category>
    <category>
      <category>Phenethylamines</category>
      <mesh-id>D010627</mesh-id>
    </category>
    <category>
      <category>Phenylalanine Hydroxylase Activator</category>
      <mesh-id/>
    </category>
    <category>
      <category>Phenylalanine Hydroxylase Activators</category>
      <mesh-id/>
    </category>
    <category>
      <category>Pigments, Biological</category>
      <mesh-id>D010860</mesh-id>
    </category>
    <category>
      <category>Pteridines</category>
      <mesh-id>D011621</mesh-id>
    </category>
    <category>
      <category>Pterins</category>
      <mesh-id>D011622</mesh-id>
    </category>
    <category>
      <category>Supplements</category>
      <mesh-id/>
    </category>
    <category>
      <category>Various Alimentary Tract and Metabolism Products</category>
      <mesh-id/>
    </category>
  </categories>
  <affected-organisms>
    <affected-organism>Humans and other mammals</affected-organism>
  </affected-organisms>
  <dosages>
    <dosage>
      <form>Powder</form>
      <route>Oral</route>
      <strength>100 mg</strength>
    </dosage>
    <dosage>
      <form>Powder</form>
      <route>Oral</route>
      <strength>500 mg</strength>
    </dosage>
    <dosage>
      <form>Powder, for solution</form>
      <route>Oral</route>
      <strength>100 mg/1</strength>
    </dosage>
    <dosage>
      <form>Powder, for solution</form>
      <route>Oral</route>
      <strength>500 mg/1</strength>
    </dosage>
    <dosage>
      <form>Tablet</form>
      <route>Oral</route>
      <strength>100 mg</strength>
    </dosage>
    <dosage>
      <form>Tablet</form>
      <route>Oral</route>
      <strength>100 mg/1</strength>
    </dosage>
  </dosages>
  <atc-codes>
    <atc-code code="A16AX07">
      <level code="A16AX">Various alimentary tract and metabolism products</level>
      <level code="A16A">OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS</level>
      <level code="A16">OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS</level>
      <level code="A">ALIMENTARY TRACT AND METABOLISM</level>
    </atc-code>
  </atc-codes>
  <ahfs-codes>
    <ahfs-code>92:92.00</ahfs-code>
  </ahfs-codes>
  <pdb-entries>
    <pdb-entry>1d1v</pdb-entry>
    <pdb-entry>1d1w</pdb-entry>
    <pdb-entry>1d1x</pdb-entry>
    <pdb-entry>1df1</pdb-entry>
    <pdb-entry>1dm8</pdb-entry>
    <pdb-entry>1dwx</pdb-entry>
    <pdb-entry>1fop</pdb-entry>
    <pdb-entry>1j8u</pdb-entry>
    <pdb-entry>1jwj</pdb-entry>
    <pdb-entry>1k2r</pdb-entry>
    <pdb-entry>1k2s</pdb-entry>
    <pdb-entry>1k2t</pdb-entry>
    <pdb-entry>1k2u</pdb-entry>
    <pdb-entry>1kw0</pdb-entry>
    <pdb-entry>1lzx</pdb-entry>
    <pdb-entry>1lzz</pdb-entry>
    <pdb-entry>1m00</pdb-entry>
    <pdb-entry>1m8d</pdb-entry>
    <pdb-entry>1m8e</pdb-entry>
    <pdb-entry>1m8h</pdb-entry>
    <pdb-entry>1m8i</pdb-entry>
    <pdb-entry>1m9t</pdb-entry>
    <pdb-entry>1mmk</pdb-entry>
    <pdb-entry>1mmt</pdb-entry>
    <pdb-entry>1mmv</pdb-entry>
    <pdb-entry>1mmw</pdb-entry>
    <pdb-entry>1n2n</pdb-entry>
    <pdb-entry>1nod</pdb-entry>
    <pdb-entry>1nse</pdb-entry>
    <pdb-entry>1nsi</pdb-entry>
    <pdb-entry>1om4</pdb-entry>
    <pdb-entry>1om5</pdb-entry>
    <pdb-entry>1p6h</pdb-entry>
    <pdb-entry>1p6i</pdb-entry>
    <pdb-entry>1p6j</pdb-entry>
    <pdb-entry>1p6k</pdb-entry>
    <pdb-entry>1p6l</pdb-entry>
    <pdb-entry>1p6m</pdb-entry>
    <pdb-entry>1p6n</pdb-entry>
    <pdb-entry>1q2o</pdb-entry>
    <pdb-entry>1qom</pdb-entry>
    <pdb-entry>1qw4</pdb-entry>
    <pdb-entry>1qw5</pdb-entry>
    <pdb-entry>1qw6</pdb-entry>
    <pdb-entry>1qwc</pdb-entry>
    <pdb-entry>1r35</pdb-entry>
    <pdb-entry>1rs6</pdb-entry>
    <pdb-entry>1rs7</pdb-entry>
    <pdb-entry>1rs8</pdb-entry>
    <pdb-entry>1rs9</pdb-entry>
    <pdb-entry>1vaf</pdb-entry>
    <pdb-entry>1vag</pdb-entry>
    <pdb-entry>1zvi</pdb-entry>
    <pdb-entry>1zvl</pdb-entry>
    <pdb-entry>1zzq</pdb-entry>
    <pdb-entry>1zzr</pdb-entry>
    <pdb-entry>1zzs</pdb-entry>
    <pdb-entry>1zzt</pdb-entry>
    <pdb-entry>1zzu</pdb-entry>
    <pdb-entry>2an2</pdb-entry>
    <pdb-entry>2bfp</pdb-entry>
    <pdb-entry>2dtt</pdb-entry>
    <pdb-entry>2g6h</pdb-entry>
    <pdb-entry>2g6k</pdb-entry>
    <pdb-entry>2g6m</pdb-entry>
    <pdb-entry>2hx2</pdb-entry>
    <pdb-entry>2hx3</pdb-entry>
    <pdb-entry>2hx4</pdb-entry>
    <pdb-entry>2nod</pdb-entry>
    <pdb-entry>2nse</pdb-entry>
    <pdb-entry>2nsi</pdb-entry>
    <pdb-entry>2y37</pdb-entry>
    <pdb-entry>3b3m</pdb-entry>
    <pdb-entry>3b3n</pdb-entry>
    <pdb-entry>3b3o</pdb-entry>
    <pdb-entry>3b3p</pdb-entry>
    <pdb-entry>3dqr</pdb-entry>
    <pdb-entry>3dqs</pdb-entry>
    <pdb-entry>3dqt</pdb-entry>
    <pdb-entry>3dwj</pdb-entry>
    <pdb-entry>3e65</pdb-entry>
    <pdb-entry>3e67</pdb-entry>
    <pdb-entry>3e68</pdb-entry>
    <pdb-entry>3e6l</pdb-entry>
    <pdb-entry>3e6n</pdb-entry>
    <pdb-entry>3e6o</pdb-entry>
    <pdb-entry>3e6t</pdb-entry>
    <pdb-entry>3e7g</pdb-entry>
    <pdb-entry>3e7i</pdb-entry>
    <pdb-entry>3e7m</pdb-entry>
    <pdb-entry>3eai</pdb-entry>
    <pdb-entry>3ebd</pdb-entry>
    <pdb-entry>3ebf</pdb-entry>
    <pdb-entry>3ej8</pdb-entry>
    <pdb-entry>3fc5</pdb-entry>
    <pdb-entry>3hsn</pdb-entry>
    <pdb-entry>3hso</pdb-entry>
    <pdb-entry>3hsp</pdb-entry>
    <pdb-entry>3jt3</pdb-entry>
    <pdb-entry>3jt4</pdb-entry>
    <pdb-entry>3jt5</pdb-entry>
    <pdb-entry>3jt6</pdb-entry>
    <pdb-entry>3jt7</pdb-entry>
    <pdb-entry>3jt8</pdb-entry>
    <pdb-entry>3jt9</pdb-entry>
    <pdb-entry>3jta</pdb-entry>
    <pdb-entry>3jws</pdb-entry>
    <pdb-entry>3jwt</pdb-entry>
    <pdb-entry>3jwu</pdb-entry>
    <pdb-entry>3jwv</pdb-entry>
    <pdb-entry>3jww</pdb-entry>
    <pdb-entry>3jwx</pdb-entry>
    <pdb-entry>3jwy</pdb-entry>
    <pdb-entry>3jwz</pdb-entry>
    <pdb-entry>3jx0</pdb-entry>
    <pdb-entry>3jx1</pdb-entry>
    <pdb-entry>3jx2</pdb-entry>
    <pdb-entry>3jx3</pdb-entry>
    <pdb-entry>3jx4</pdb-entry>
    <pdb-entry>3jx5</pdb-entry>
    <pdb-entry>3jx6</pdb-entry>
    <pdb-entry>3n2r</pdb-entry>
    <pdb-entry>3n5p</pdb-entry>
    <pdb-entry>3n5q</pdb-entry>
    <pdb-entry>3n5r</pdb-entry>
    <pdb-entry>3n5s</pdb-entry>
    <pdb-entry>3n5t</pdb-entry>
    <pdb-entry>3n5v</pdb-entry>
    <pdb-entry>3n5y</pdb-entry>
    <pdb-entry>3n5z</pdb-entry>
    <pdb-entry>3n61</pdb-entry>
    <pdb-entry>3n62</pdb-entry>
    <pdb-entry>3n65</pdb-entry>
    <pdb-entry>3n67</pdb-entry>
    <pdb-entry>3n68</pdb-entry>
    <pdb-entry>3n69</pdb-entry>
    <pdb-entry>3n6a</pdb-entry>
    <pdb-entry>3n6b</pdb-entry>
    <pdb-entry>3n6c</pdb-entry>
    <pdb-entry>3n6d</pdb-entry>
    <pdb-entry>3n6e</pdb-entry>
    <pdb-entry>3n6f</pdb-entry>
    <pdb-entry>3n6g</pdb-entry>
    <pdb-entry>3nld</pdb-entry>
    <pdb-entry>3nle</pdb-entry>
    <pdb-entry>3nlf</pdb-entry>
    <pdb-entry>3nlg</pdb-entry>
    <pdb-entry>3nlh</pdb-entry>
    <pdb-entry>3nli</pdb-entry>
    <pdb-entry>3nlj</pdb-entry>
    <pdb-entry>3nlk</pdb-entry>
    <pdb-entry>3nlm</pdb-entry>
    <pdb-entry>3nln</pdb-entry>
    <pdb-entry>3nlo</pdb-entry>
    <pdb-entry>3nlp</pdb-entry>
    <pdb-entry>3nlq</pdb-entry>
    <pdb-entry>3nlr</pdb-entry>
    <pdb-entry>3nlt</pdb-entry>
    <pdb-entry>3nlu</pdb-entry>
    <pdb-entry>3nlv</pdb-entry>
    <pdb-entry>3nlw</pdb-entry>
    <pdb-entry>3nlx</pdb-entry>
    <pdb-entry>3nly</pdb-entry>
    <pdb-entry>3nlz</pdb-entry>
    <pdb-entry>3nm0</pdb-entry>
    <pdb-entry>3nny</pdb-entry>
    <pdb-entry>3nnz</pdb-entry>
    <pdb-entry>3nod</pdb-entry>
    <pdb-entry>3nos</pdb-entry>
    <pdb-entry>3nqs</pdb-entry>
    <pdb-entry>3nw2</pdb-entry>
    <pdb-entry>3pne</pdb-entry>
    <pdb-entry>3pnf</pdb-entry>
    <pdb-entry>3png</pdb-entry>
    <pdb-entry>3pnh</pdb-entry>
    <pdb-entry>3q99</pdb-entry>
    <pdb-entry>3q9a</pdb-entry>
    <pdb-entry>3rqj</pdb-entry>
    <pdb-entry>3rqk</pdb-entry>
    <pdb-entry>3rql</pdb-entry>
    <pdb-entry>3rqm</pdb-entry>
    <pdb-entry>3rqn</pdb-entry>
    <pdb-entry>3rqo</pdb-entry>
    <pdb-entry>3rqp</pdb-entry>
    <pdb-entry>3svp</pdb-entry>
    <pdb-entry>3svq</pdb-entry>
    <pdb-entry>3tyl</pdb-entry>
    <pdb-entry>3tym</pdb-entry>
    <pdb-entry>3tyn</pdb-entry>
    <pdb-entry>3tyo</pdb-entry>
    <pdb-entry>3ufo</pdb-entry>
    <pdb-entry>3ufp</pdb-entry>
    <pdb-entry>3ufq</pdb-entry>
    <pdb-entry>3ufr</pdb-entry>
    <pdb-entry>3ufs</pdb-entry>
    <pdb-entry>3uft</pdb-entry>
    <pdb-entry>3ufu</pdb-entry>
    <pdb-entry>3ufv</pdb-entry>
    <pdb-entry>3ufw</pdb-entry>
    <pdb-entry>4c39</pdb-entry>
    <pdb-entry>4c3a</pdb-entry>
    <pdb-entry>4cam</pdb-entry>
    <pdb-entry>4can</pdb-entry>
    <pdb-entry>4cao</pdb-entry>
    <pdb-entry>4cap</pdb-entry>
    <pdb-entry>4caq</pdb-entry>
    <pdb-entry>4car</pdb-entry>
    <pdb-entry>4cdt</pdb-entry>
    <pdb-entry>4cft</pdb-entry>
    <pdb-entry>4ctp</pdb-entry>
    <pdb-entry>4ctq</pdb-entry>
    <pdb-entry>4ctr</pdb-entry>
    <pdb-entry>4ctt</pdb-entry>
    <pdb-entry>4ctu</pdb-entry>
    <pdb-entry>4ctv</pdb-entry>
    <pdb-entry>4ctw</pdb-entry>
    <pdb-entry>4ctx</pdb-entry>
    <pdb-entry>4cty</pdb-entry>
    <pdb-entry>4ctz</pdb-entry>
    <pdb-entry>4cu0</pdb-entry>
    <pdb-entry>4cu1</pdb-entry>
    <pdb-entry>4cwv</pdb-entry>
    <pdb-entry>4cww</pdb-entry>
    <pdb-entry>4cwx</pdb-entry>
    <pdb-entry>4cwy</pdb-entry>
    <pdb-entry>4cwz</pdb-entry>
    <pdb-entry>4cx0</pdb-entry>
    <pdb-entry>4cx3</pdb-entry>
    <pdb-entry>4cx4</pdb-entry>
    <pdb-entry>4cx5</pdb-entry>
    <pdb-entry>4cx6</pdb-entry>
    <pdb-entry>4cx7</pdb-entry>
    <pdb-entry>4d1n</pdb-entry>
    <pdb-entry>4d1o</pdb-entry>
    <pdb-entry>4d1p</pdb-entry>
    <pdb-entry>4d2y</pdb-entry>
    <pdb-entry>4d2z</pdb-entry>
    <pdb-entry>4d30</pdb-entry>
    <pdb-entry>4d31</pdb-entry>
    <pdb-entry>4d32</pdb-entry>
    <pdb-entry>4d33</pdb-entry>
    <pdb-entry>4d34</pdb-entry>
    <pdb-entry>4d35</pdb-entry>
    <pdb-entry>4d36</pdb-entry>
    <pdb-entry>4d37</pdb-entry>
    <pdb-entry>4d38</pdb-entry>
    <pdb-entry>4d39</pdb-entry>
    <pdb-entry>4d3a</pdb-entry>
    <pdb-entry>4d3b</pdb-entry>
    <pdb-entry>4d7h</pdb-entry>
    <pdb-entry>4d7i</pdb-entry>
    <pdb-entry>4d7j</pdb-entry>
    <pdb-entry>4d7o</pdb-entry>
    <pdb-entry>4eux</pdb-entry>
    <pdb-entry>4fvw</pdb-entry>
    <pdb-entry>4fvx</pdb-entry>
    <pdb-entry>4fvy</pdb-entry>
    <pdb-entry>4fvz</pdb-entry>
    <pdb-entry>4fw0</pdb-entry>
    <pdb-entry>4gqe</pdb-entry>
    <pdb-entry>4imt</pdb-entry>
    <pdb-entry>4imu</pdb-entry>
    <pdb-entry>4imw</pdb-entry>
    <pdb-entry>4imx</pdb-entry>
    <pdb-entry>4js9</pdb-entry>
    <pdb-entry>4jse</pdb-entry>
    <pdb-entry>4jsf</pdb-entry>
    <pdb-entry>4jsg</pdb-entry>
    <pdb-entry>4jsh</pdb-entry>
    <pdb-entry>4jsi</pdb-entry>
    <pdb-entry>4jsj</pdb-entry>
    <pdb-entry>4jsk</pdb-entry>
    <pdb-entry>4jsl</pdb-entry>
    <pdb-entry>4jsm</pdb-entry>
    <pdb-entry>4k5d</pdb-entry>
    <pdb-entry>4k5e</pdb-entry>
    <pdb-entry>4k5f</pdb-entry>
    <pdb-entry>4k5g</pdb-entry>
    <pdb-entry>4k5h</pdb-entry>
    <pdb-entry>4k5i</pdb-entry>
    <pdb-entry>4k5j</pdb-entry>
    <pdb-entry>4k5k</pdb-entry>
    <pdb-entry>4kch</pdb-entry>
    <pdb-entry>4kci</pdb-entry>
    <pdb-entry>4kcj</pdb-entry>
    <pdb-entry>4kck</pdb-entry>
    <pdb-entry>4kcl</pdb-entry>
    <pdb-entry>4kcm</pdb-entry>
    <pdb-entry>4kcn</pdb-entry>
    <pdb-entry>4kco</pdb-entry>
    <pdb-entry>4kcp</pdb-entry>
    <pdb-entry>4kcq</pdb-entry>
    <pdb-entry>4kcr</pdb-entry>
    <pdb-entry>4kcs</pdb-entry>
    <pdb-entry>4luw</pdb-entry>
    <pdb-entry>4lux</pdb-entry>
    <pdb-entry>4lvx</pdb-entry>
    <pdb-entry>4lwb</pdb-entry>
    <pdb-entry>4nos</pdb-entry>
    <pdb-entry>4uch</pdb-entry>
    <pdb-entry>4ug5</pdb-entry>
    <pdb-entry>4ug6</pdb-entry>
    <pdb-entry>4ug7</pdb-entry>
    <pdb-entry>4ug8</pdb-entry>
    <pdb-entry>4uga</pdb-entry>
    <pdb-entry>4ugb</pdb-entry>
    <pdb-entry>4ugc</pdb-entry>
    <pdb-entry>4ugd</pdb-entry>
    <pdb-entry>4uge</pdb-entry>
    <pdb-entry>4ugf</pdb-entry>
    <pdb-entry>4ugg</pdb-entry>
    <pdb-entry>4ugh</pdb-entry>
    <pdb-entry>4ugj</pdb-entry>
    <pdb-entry>4ugk</pdb-entry>
    <pdb-entry>4ugl</pdb-entry>
    <pdb-entry>4ugm</pdb-entry>
    <pdb-entry>4ugn</pdb-entry>
    <pdb-entry>4ugo</pdb-entry>
    <pdb-entry>4ugp</pdb-entry>
    <pdb-entry>4ugq</pdb-entry>
    <pdb-entry>4ugr</pdb-entry>
    <pdb-entry>4ugs</pdb-entry>
    <pdb-entry>4ugt</pdb-entry>
    <pdb-entry>4ugu</pdb-entry>
    <pdb-entry>4ugv</pdb-entry>
    <pdb-entry>4ugw</pdb-entry>
    <pdb-entry>4ugx</pdb-entry>
    <pdb-entry>4ugy</pdb-entry>
    <pdb-entry>4ugz</pdb-entry>
    <pdb-entry>4uh0</pdb-entry>
    <pdb-entry>4uh1</pdb-entry>
    <pdb-entry>4uh2</pdb-entry>
    <pdb-entry>4uh3</pdb-entry>
    <pdb-entry>4uh4</pdb-entry>
    <pdb-entry>4uh5</pdb-entry>
    <pdb-entry>4uh6</pdb-entry>
    <pdb-entry>4uh7</pdb-entry>
    <pdb-entry>4uh8</pdb-entry>
    <pdb-entry>4uh9</pdb-entry>
    <pdb-entry>4uha</pdb-entry>
    <pdb-entry>4upm</pdb-entry>
    <pdb-entry>4upn</pdb-entry>
    <pdb-entry>4upo</pdb-entry>
    <pdb-entry>4upp</pdb-entry>
    <pdb-entry>4upq</pdb-entry>
    <pdb-entry>4upr</pdb-entry>
    <pdb-entry>4ups</pdb-entry>
    <pdb-entry>4upt</pdb-entry>
    <pdb-entry>4uqr</pdb-entry>
    <pdb-entry>4ux6</pdb-entry>
    <pdb-entry>4v3u</pdb-entry>
    <pdb-entry>4v3v</pdb-entry>
    <pdb-entry>4v3w</pdb-entry>
    <pdb-entry>4v3x</pdb-entry>
    <pdb-entry>4v3y</pdb-entry>
    <pdb-entry>4v3z</pdb-entry>
    <pdb-entry>5ad4</pdb-entry>
    <pdb-entry>5ad5</pdb-entry>
    <pdb-entry>5ad6</pdb-entry>
    <pdb-entry>5ad7</pdb-entry>
    <pdb-entry>5ad8</pdb-entry>
    <pdb-entry>5ad9</pdb-entry>
    <pdb-entry>5ada</pdb-entry>
    <pdb-entry>5adb</pdb-entry>
    <pdb-entry>5adc</pdb-entry>
    <pdb-entry>5add</pdb-entry>
    <pdb-entry>5ade</pdb-entry>
    <pdb-entry>5adf</pdb-entry>
    <pdb-entry>5adg</pdb-entry>
    <pdb-entry>5adi</pdb-entry>
    <pdb-entry>5adj</pdb-entry>
    <pdb-entry>5adk</pdb-entry>
    <pdb-entry>5adl</pdb-entry>
    <pdb-entry>5adm</pdb-entry>
    <pdb-entry>5adn</pdb-entry>
    <pdb-entry>5agk</pdb-entry>
    <pdb-entry>5agl</pdb-entry>
    <pdb-entry>5agm</pdb-entry>
    <pdb-entry>5agn</pdb-entry>
    <pdb-entry>5ago</pdb-entry>
    <pdb-entry>5agp</pdb-entry>
    <pdb-entry>5fj2</pdb-entry>
    <pdb-entry>5fj3</pdb-entry>
    <pdb-entry>5fvo</pdb-entry>
    <pdb-entry>5fvp</pdb-entry>
    <pdb-entry>5fvq</pdb-entry>
    <pdb-entry>5fvr</pdb-entry>
    <pdb-entry>5fvs</pdb-entry>
    <pdb-entry>5fvt</pdb-entry>
    <pdb-entry>5fvu</pdb-entry>
    <pdb-entry>5fvv</pdb-entry>
    <pdb-entry>5fvw</pdb-entry>
    <pdb-entry>5fvx</pdb-entry>
    <pdb-entry>5fvy</pdb-entry>
    <pdb-entry>5fvz</pdb-entry>
    <pdb-entry>5fw0</pdb-entry>
    <pdb-entry>5g0n</pdb-entry>
    <pdb-entry>5g0o</pdb-entry>
    <pdb-entry>5g0p</pdb-entry>
    <pdb-entry>5g67</pdb-entry>
    <pdb-entry>5g68</pdb-entry>
    <pdb-entry>5g69</pdb-entry>
    <pdb-entry>5g6a</pdb-entry>
    <pdb-entry>5g6c</pdb-entry>
    <pdb-entry>5g6d</pdb-entry>
    <pdb-entry>5g6e</pdb-entry>
    <pdb-entry>5g6f</pdb-entry>
    <pdb-entry>5g6g</pdb-entry>
    <pdb-entry>5g6h</pdb-entry>
    <pdb-entry>5g6i</pdb-entry>
    <pdb-entry>5g6k</pdb-entry>
    <pdb-entry>5g6l</pdb-entry>
    <pdb-entry>5g6m</pdb-entry>
    <pdb-entry>5g6n</pdb-entry>
    <pdb-entry>5g6q</pdb-entry>
    <pdb-entry>5unr</pdb-entry>
    <pdb-entry>5uns</pdb-entry>
    <pdb-entry>5unt</pdb-entry>
    <pdb-entry>5unu</pdb-entry>
    <pdb-entry>5unv</pdb-entry>
    <pdb-entry>5unw</pdb-entry>
    <pdb-entry>5unx</pdb-entry>
    <pdb-entry>5uny</pdb-entry>
    <pdb-entry>5unz</pdb-entry>
    <pdb-entry>5uo0</pdb-entry>
    <pdb-entry>5uo1</pdb-entry>
    <pdb-entry>5uo2</pdb-entry>
    <pdb-entry>5uo3</pdb-entry>
    <pdb-entry>5uo4</pdb-entry>
    <pdb-entry>5uo5</pdb-entry>
    <pdb-entry>5uo6</pdb-entry>
    <pdb-entry>5uo7</pdb-entry>
    <pdb-entry>5uo8</pdb-entry>
    <pdb-entry>5uo9</pdb-entry>
    <pdb-entry>5uoc</pdb-entry>
    <pdb-entry>5uod</pdb-entry>
    <pdb-entry>5vui</pdb-entry>
    <pdb-entry>5vuj</pdb-entry>
    <pdb-entry>5vuk</pdb-entry>
    <pdb-entry>5vul</pdb-entry>
    <pdb-entry>5vum</pdb-entry>
    <pdb-entry>5vun</pdb-entry>
    <pdb-entry>5vuo</pdb-entry>
    <pdb-entry>5vup</pdb-entry>
    <pdb-entry>5vuq</pdb-entry>
    <pdb-entry>5vur</pdb-entry>
    <pdb-entry>5vus</pdb-entry>
    <pdb-entry>5vut</pdb-entry>
    <pdb-entry>5vuu</pdb-entry>
    <pdb-entry>5vuv</pdb-entry>
    <pdb-entry>5vuw</pdb-entry>
    <pdb-entry>5vux</pdb-entry>
    <pdb-entry>5vuy</pdb-entry>
    <pdb-entry>5vuz</pdb-entry>
    <pdb-entry>5vv0</pdb-entry>
    <pdb-entry>5vv1</pdb-entry>
    <pdb-entry>5vv2</pdb-entry>
    <pdb-entry>5vv3</pdb-entry>
    <pdb-entry>5vv4</pdb-entry>
    <pdb-entry>5vv5</pdb-entry>
    <pdb-entry>5vv6</pdb-entry>
    <pdb-entry>5vv7</pdb-entry>
    <pdb-entry>5vv8</pdb-entry>
    <pdb-entry>5vv9</pdb-entry>
    <pdb-entry>5vva</pdb-entry>
    <pdb-entry>5vvb</pdb-entry>
    <pdb-entry>5vvc</pdb-entry>
    <pdb-entry>5vvd</pdb-entry>
    <pdb-entry>5vvg</pdb-entry>
    <pdb-entry>5vvn</pdb-entry>
    <pdb-entry>6auq</pdb-entry>
    <pdb-entry>6aur</pdb-entry>
    <pdb-entry>6aus</pdb-entry>
    <pdb-entry>6aut</pdb-entry>
    <pdb-entry>6auu</pdb-entry>
    <pdb-entry>6auv</pdb-entry>
    <pdb-entry>6auw</pdb-entry>
    <pdb-entry>6aux</pdb-entry>
    <pdb-entry>6auy</pdb-entry>
    <pdb-entry>6auz</pdb-entry>
    <pdb-entry>6av0</pdb-entry>
    <pdb-entry>6av1</pdb-entry>
    <pdb-entry>6av2</pdb-entry>
    <pdb-entry>6av3</pdb-entry>
    <pdb-entry>6av4</pdb-entry>
    <pdb-entry>6av5</pdb-entry>
    <pdb-entry>6av6</pdb-entry>
    <pdb-entry>6av7</pdb-entry>
    <pdb-entry>6cic</pdb-entry>
    <pdb-entry>6cid</pdb-entry>
    <pdb-entry>6cie</pdb-entry>
    <pdb-entry>6cif</pdb-entry>
    <pdb-entry>6hyc</pdb-entry>
    <pdb-entry>6ng1</pdb-entry>
    <pdb-entry>6ng2</pdb-entry>
    <pdb-entry>6ng4</pdb-entry>
    <pdb-entry>6ng5</pdb-entry>
    <pdb-entry>6ng6</pdb-entry>
    <pdb-entry>6ng7</pdb-entry>
    <pdb-entry>6ng8</pdb-entry>
    <pdb-entry>6nga</pdb-entry>
    <pdb-entry>6ngb</pdb-entry>
    <pdb-entry>6ngc</pdb-entry>
    <pdb-entry>6ngd</pdb-entry>
    <pdb-entry>6nge</pdb-entry>
    <pdb-entry>6ngf</pdb-entry>
    <pdb-entry>6ngh</pdb-entry>
    <pdb-entry>6ngi</pdb-entry>
    <pdb-entry>6ngj</pdb-entry>
    <pdb-entry>6ngk</pdb-entry>
    <pdb-entry>6ngl</pdb-entry>
    <pdb-entry>6ngm</pdb-entry>
    <pdb-entry>6ngn</pdb-entry>
    <pdb-entry>6ngp</pdb-entry>
    <pdb-entry>6ngq</pdb-entry>
    <pdb-entry>6ngr</pdb-entry>
    <pdb-entry>6ngs</pdb-entry>
    <pdb-entry>6ngt</pdb-entry>
    <pdb-entry>6ngu</pdb-entry>
    <pdb-entry>6ngv</pdb-entry>
    <pdb-entry>6ngw</pdb-entry>
    <pdb-entry>6ngx</pdb-entry>
    <pdb-entry>6ngy</pdb-entry>
    <pdb-entry>6ngz</pdb-entry>
    <pdb-entry>6nh0</pdb-entry>
    <pdb-entry>6nh1</pdb-entry>
    <pdb-entry>6nh2</pdb-entry>
    <pdb-entry>6nh4</pdb-entry>
    <pdb-entry>6nh5</pdb-entry>
    <pdb-entry>6nh6</pdb-entry>
    <pdb-entry>6nh8</pdb-entry>
    <pdb-entry>6nhb</pdb-entry>
    <pdb-entry>6nhc</pdb-entry>
    <pdb-entry>6nhd</pdb-entry>
    <pdb-entry>6nhe</pdb-entry>
    <pdb-entry>6nhf</pdb-entry>
    <pdb-entry>8nse</pdb-entry>
    <pdb-entry>9nse</pdb-entry>
  </pdb-entries>
  <patents>
    <patent>
      <number>2545968</number>
      <country>Canada</country>
      <approved>2010-03-09</approved>
      <expires>2024-11-17</expires>
      <pediatric-extension>false</pediatric-extension>
    </patent>
    <patent>
      <number>7566714</number>
      <country>United States</country>
      <approved>2009-07-28</approved>
      <expires>2025-05-17</expires>
      <pediatric-extension>true</pediatric-extension>
    </patent>
    <patent>
      <number>7612073</number>
      <country>United States</country>
      <approved>2009-11-03</approved>
      <expires>2025-05-17</expires>
      <pediatric-extension>true</pediatric-extension>
    </patent>
    <patent>
      <number>8067416</number>
      <country>United States</country>
      <approved>2011-11-29</approved>
      <expires>2025-05-17</expires>
      <pediatric-extension>true</pediatric-extension>
    </patent>
    <patent>
      <number>RE43797</number>
      <country>United States</country>
      <approved>2012-11-06</approved>
      <expires>2025-05-17</expires>
      <pediatric-extension>true</pediatric-extension>
    </patent>
    <patent>
      <number>7947681</number>
      <country>United States</country>
      <approved>2011-05-24</approved>
      <expires>2025-05-17</expires>
      <pediatric-extension>true</pediatric-extension>
    </patent>
    <patent>
      <number>7566462</number>
      <country>United States</country>
      <approved>2009-07-28</approved>
      <expires>2026-05-16</expires>
      <pediatric-extension>true</pediatric-extension>
    </patent>
    <patent>
      <number>8318745</number>
      <country>United States</country>
      <approved>2012-11-27</approved>
      <expires>2025-05-17</expires>
      <pediatric-extension>true</pediatric-extension>
    </patent>
    <patent>
      <number>8003126</number>
      <country>United States</country>
      <approved>2011-08-23</approved>
      <expires>2026-05-16</expires>
      <pediatric-extension>true</pediatric-extension>
    </patent>
    <patent>
      <number>7727987</number>
      <country>United States</country>
      <approved>2010-06-01</approved>
      <expires>2025-05-17</expires>
      <pediatric-extension>true</pediatric-extension>
    </patent>
    <patent>
      <number>9216178</number>
      <country>United States</country>
      <approved>2015-12-22</approved>
      <expires>2032-11-01</expires>
      <pediatric-extension>false</pediatric-extension>
    </patent>
    <patent>
      <number>9433624</number>
      <country>United States</country>
      <approved>2016-09-06</approved>
      <expires>2024-11-17</expires>
      <pediatric-extension>false</pediatric-extension>
    </patent>
  </patents>
  <food-interactions/>
  <drug-interactions>
    <drug-interaction>
      <drugbank-id>DB01235</drugbank-id>
      <name>Levodopa</name>
      <description>The risk or severity of adverse effects can be increased when Sapropterin is combined with Levodopa.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00563</drugbank-id>
      <name>Methotrexate</name>
      <description>The serum concentration of Sapropterin can be decreased when it is combined with Methotrexate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06813</drugbank-id>
      <name>Pralatrexate</name>
      <description>The serum concentration of Sapropterin can be decreased when it is combined with Pralatrexate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00203</drugbank-id>
      <name>Sildenafil</name>
      <description>Sapropterin may increase the hypotensive activities of Sildenafil.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00820</drugbank-id>
      <name>Tadalafil</name>
      <description>Sapropterin may increase the hypotensive activities of Tadalafil.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00862</drugbank-id>
      <name>Vardenafil</name>
      <description>Sapropterin may increase the hypotensive activities of Vardenafil.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06267</drugbank-id>
      <name>Udenafil</name>
      <description>Sapropterin may increase the hypotensive activities of Udenafil.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11792</drugbank-id>
      <name>Mirodenafil</name>
      <description>Sapropterin may increase the hypotensive activities of Mirodenafil.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06237</drugbank-id>
      <name>Avanafil</name>
      <description>Sapropterin may increase the hypotensive activities of Avanafil.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00975</drugbank-id>
      <name>Dipyridamole</name>
      <description>Sapropterin may increase the hypotensive activities of Dipyridamole.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00806</drugbank-id>
      <name>Pentoxifylline</name>
      <description>Sapropterin may increase the hypotensive activities of Pentoxifylline.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00277</drugbank-id>
      <name>Theophylline</name>
      <description>Sapropterin may increase the hypotensive activities of Theophylline.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12010</drugbank-id>
      <name>Fostamatinib</name>
      <description>Sapropterin may increase the hypotensive activities of Fostamatinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00235</drugbank-id>
      <name>Milrinone</name>
      <description>Sapropterin may increase the hypotensive activities of Milrinone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00261</drugbank-id>
      <name>Anagrelide</name>
      <description>Sapropterin may increase the hypotensive activities of Anagrelide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05266</drugbank-id>
      <name>Ibudilast</name>
      <description>Sapropterin may increase the hypotensive activities of Ibudilast.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09273</drugbank-id>
      <name>Doxofylline</name>
      <description>Sapropterin may increase the hypotensive activities of Doxofylline.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08916</drugbank-id>
      <name>Afatinib</name>
      <description>The serum concentration of Afatinib can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06616</drugbank-id>
      <name>Bosutinib</name>
      <description>The serum concentration of Bosutinib can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08870</drugbank-id>
      <name>Brentuximab vedotin</name>
      <description>The serum concentration of Brentuximab vedotin can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01394</drugbank-id>
      <name>Colchicine</name>
      <description>The serum concentration of Colchicine can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09075</drugbank-id>
      <name>Edoxaban</name>
      <description>The serum concentration of Edoxaban can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09027</drugbank-id>
      <name>Ledipasvir</name>
      <description>The serum concentration of Ledipasvir can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09049</drugbank-id>
      <name>Naloxegol</name>
      <description>The serum concentration of Naloxegol can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06589</drugbank-id>
      <name>Pazopanib</name>
      <description>The serum concentration of Pazopanib can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06480</drugbank-id>
      <name>Prucalopride</name>
      <description>The serum concentration of Prucalopride can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00243</drugbank-id>
      <name>Ranolazine</name>
      <description>The serum concentration of Ranolazine can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06207</drugbank-id>
      <name>Silodosin</name>
      <description>The serum concentration of Silodosin can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01030</drugbank-id>
      <name>Topotecan</name>
      <description>The serum concentration of Topotecan can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01590</drugbank-id>
      <name>Everolimus</name>
      <description>The serum concentration of Everolimus can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01220</drugbank-id>
      <name>Rifaximin</name>
      <description>The serum concentration of Rifaximin can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00541</drugbank-id>
      <name>Vincristine</name>
      <description>The excretion of Vincristine can be decreased when combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00997</drugbank-id>
      <name>Doxorubicin</name>
      <description>The serum concentration of Doxorubicin can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12364</drugbank-id>
      <name>Betrixaban</name>
      <description>The serum concentration of Betrixaban can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06695</drugbank-id>
      <name>Dabigatran etexilate</name>
      <description>The serum concentration of Dabigatran etexilate can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00091</drugbank-id>
      <name>Cyclosporine</name>
      <description>The serum concentration of Cyclosporine can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00252</drugbank-id>
      <name>Phenytoin</name>
      <description>The serum concentration of Phenytoin can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00321</drugbank-id>
      <name>Amitriptyline</name>
      <description>The serum concentration of Amitriptyline can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00458</drugbank-id>
      <name>Imipramine</name>
      <description>The serum concentration of Imipramine can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00564</drugbank-id>
      <name>Carbamazepine</name>
      <description>The serum concentration of Carbamazepine can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00575</drugbank-id>
      <name>Clonidine</name>
      <description>The serum concentration of Clonidine can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00726</drugbank-id>
      <name>Trimipramine</name>
      <description>The serum concentration of Trimipramine can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00864</drugbank-id>
      <name>Tacrolimus</name>
      <description>The serum concentration of Tacrolimus can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00877</drugbank-id>
      <name>Sirolimus</name>
      <description>The serum concentration of Sirolimus can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00908</drugbank-id>
      <name>Quinidine</name>
      <description>The serum concentration of Quinidine can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01045</drugbank-id>
      <name>Rifampicin</name>
      <description>The serum concentration of Rifampicin can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01174</drugbank-id>
      <name>Phenobarbital</name>
      <description>The serum concentration of Phenobarbital can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01229</drugbank-id>
      <name>Paclitaxel</name>
      <description>The serum concentration of Paclitaxel can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01396</drugbank-id>
      <name>Digitoxin</name>
      <description>The serum concentration of Digitoxin can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06287</drugbank-id>
      <name>Temsirolimus</name>
      <description>The serum concentration of Temsirolimus can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00390</drugbank-id>
      <name>Digoxin</name>
      <description>Sapropterin may decrease the excretion rate of Digoxin which could result in a higher serum level.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13401</drugbank-id>
      <name>Metildigoxin</name>
      <description>Sapropterin may decrease the excretion rate of Metildigoxin which could result in a higher serum level.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13691</drugbank-id>
      <name>Acetyldigoxin</name>
      <description>Sapropterin may decrease the excretion rate of Acetyldigoxin which could result in a higher serum level.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12825</drugbank-id>
      <name>Lefamulin</name>
      <description>Sapropterin may decrease the excretion rate of Lefamulin which could result in a higher serum level.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00027</drugbank-id>
      <name>Gramicidin D</name>
      <description>The serum concentration of Gramicidin D can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00104</drugbank-id>
      <name>Octreotide</name>
      <description>The serum concentration of Octreotide can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00126</drugbank-id>
      <name>Ascorbic acid</name>
      <description>The serum concentration of Ascorbic acid can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00175</drugbank-id>
      <name>Pravastatin</name>
      <description>The serum concentration of Pravastatin can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00193</drugbank-id>
      <name>Tramadol</name>
      <description>The serum concentration of Tramadol can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00199</drugbank-id>
      <name>Erythromycin</name>
      <description>The serum concentration of Erythromycin can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00206</drugbank-id>
      <name>Reserpine</name>
      <description>The serum concentration of Reserpine can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00207</drugbank-id>
      <name>Azithromycin</name>
      <description>The serum concentration of Azithromycin can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00213</drugbank-id>
      <name>Pantoprazole</name>
      <description>The serum concentration of Pantoprazole can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00215</drugbank-id>
      <name>Citalopram</name>
      <description>The serum concentration of Citalopram can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00216</drugbank-id>
      <name>Eletriptan</name>
      <description>The serum concentration of Eletriptan can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00220</drugbank-id>
      <name>Nelfinavir</name>
      <description>The serum concentration of Nelfinavir can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00224</drugbank-id>
      <name>Indinavir</name>
      <description>The serum concentration of Indinavir can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00248</drugbank-id>
      <name>Cabergoline</name>
      <description>The serum concentration of Cabergoline can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00255</drugbank-id>
      <name>Diethylstilbestrol</name>
      <description>The serum concentration of Diethylstilbestrol can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00264</drugbank-id>
      <name>Metoprolol</name>
      <description>The serum concentration of Metoprolol can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00273</drugbank-id>
      <name>Topiramate</name>
      <description>The serum concentration of Topiramate can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00285</drugbank-id>
      <name>Venlafaxine</name>
      <description>The serum concentration of Venlafaxine can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00286</drugbank-id>
      <name>Conjugated estrogens</name>
      <description>The serum concentration of Conjugated estrogens can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00291</drugbank-id>
      <name>Chlorambucil</name>
      <description>The serum concentration of Chlorambucil can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00295</drugbank-id>
      <name>Morphine</name>
      <description>The serum concentration of Morphine can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00300</drugbank-id>
      <name>Tenofovir disoproxil</name>
      <description>The serum concentration of Tenofovir disoproxil can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00305</drugbank-id>
      <name>Mitomycin</name>
      <description>The serum concentration of Mitomycin can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00316</drugbank-id>
      <name>Acetaminophen</name>
      <description>The serum concentration of Acetaminophen can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00317</drugbank-id>
      <name>Gefitinib</name>
      <description>The serum concentration of Gefitinib can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00328</drugbank-id>
      <name>Indomethacin</name>
      <description>The serum concentration of Indomethacin can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00334</drugbank-id>
      <name>Olanzapine</name>
      <description>The serum concentration of Olanzapine can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00338</drugbank-id>
      <name>Omeprazole</name>
      <description>The serum concentration of Omeprazole can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00341</drugbank-id>
      <name>Cetirizine</name>
      <description>The serum concentration of Cetirizine can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00342</drugbank-id>
      <name>Terfenadine</name>
      <description>The serum concentration of Terfenadine can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00343</drugbank-id>
      <name>Diltiazem</name>
      <description>The serum concentration of Diltiazem can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00349</drugbank-id>
      <name>Clobazam</name>
      <description>The serum concentration of Clobazam can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00358</drugbank-id>
      <name>Mefloquine</name>
      <description>The serum concentration of Mefloquine can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00361</drugbank-id>
      <name>Vinorelbine</name>
      <description>The serum concentration of Vinorelbine can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00363</drugbank-id>
      <name>Clozapine</name>
      <description>The serum concentration of Clozapine can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00365</drugbank-id>
      <name>Grepafloxacin</name>
      <description>The serum concentration of Grepafloxacin can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00373</drugbank-id>
      <name>Timolol</name>
      <description>The serum concentration of Timolol can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00381</drugbank-id>
      <name>Amlodipine</name>
      <description>The serum concentration of Amlodipine can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00382</drugbank-id>
      <name>Tacrine</name>
      <description>The serum concentration of Tacrine can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00394</drugbank-id>
      <name>Beclomethasone dipropionate</name>
      <description>The serum concentration of Beclomethasone dipropionate can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00396</drugbank-id>
      <name>Progesterone</name>
      <description>The serum concentration of Progesterone can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00398</drugbank-id>
      <name>Sorafenib</name>
      <description>The serum concentration of Sorafenib can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00439</drugbank-id>
      <name>Cerivastatin</name>
      <description>The serum concentration of Cerivastatin can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00441</drugbank-id>
      <name>Gemcitabine</name>
      <description>The serum concentration of Gemcitabine can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00443</drugbank-id>
      <name>Betamethasone</name>
      <description>The serum concentration of Betamethasone can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00444</drugbank-id>
      <name>Teniposide</name>
      <description>The serum concentration of Teniposide can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00448</drugbank-id>
      <name>Lansoprazole</name>
      <description>The serum concentration of Lansoprazole can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00457</drugbank-id>
      <name>Prazosin</name>
      <description>The serum concentration of Prazosin can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00468</drugbank-id>
      <name>Quinine</name>
      <description>The serum concentration of Quinine can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00477</drugbank-id>
      <name>Chlorpromazine</name>
      <description>The serum concentration of Chlorpromazine can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00480</drugbank-id>
      <name>Lenalidomide</name>
      <description>The serum concentration of Lenalidomide can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00481</drugbank-id>
      <name>Raloxifene</name>
      <description>The serum concentration of Raloxifene can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00482</drugbank-id>
      <name>Celecoxib</name>
      <description>The serum concentration of Celecoxib can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00495</drugbank-id>
      <name>Zidovudine</name>
      <description>The serum concentration of Zidovudine can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00501</drugbank-id>
      <name>Cimetidine</name>
      <description>The serum concentration of Cimetidine can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00502</drugbank-id>
      <name>Haloperidol</name>
      <description>The serum concentration of Haloperidol can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00503</drugbank-id>
      <name>Ritonavir</name>
      <description>The serum concentration of Ritonavir can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00515</drugbank-id>
      <name>Cisplatin</name>
      <description>The serum concentration of Cisplatin can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00523</drugbank-id>
      <name>Alitretinoin</name>
      <description>The serum concentration of Alitretinoin can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00530</drugbank-id>
      <name>Erlotinib</name>
      <description>The serum concentration of Erlotinib can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00537</drugbank-id>
      <name>Ciprofloxacin</name>
      <description>The serum concentration of Ciprofloxacin can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00539</drugbank-id>
      <name>Toremifene</name>
      <description>The serum concentration of Toremifene can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00555</drugbank-id>
      <name>Lamotrigine</name>
      <description>The serum concentration of Lamotrigine can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00570</drugbank-id>
      <name>Vinblastine</name>
      <description>The serum concentration of Vinblastine can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00571</drugbank-id>
      <name>Propranolol</name>
      <description>The serum concentration of Propranolol can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00585</drugbank-id>
      <name>Nizatidine</name>
      <description>The serum concentration of Nizatidine can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00588</drugbank-id>
      <name>Fluticasone propionate</name>
      <description>The serum concentration of Fluticasone propionate can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00602</drugbank-id>
      <name>Ivermectin</name>
      <description>The serum concentration of Ivermectin can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00608</drugbank-id>
      <name>Chloroquine</name>
      <description>The serum concentration of Chloroquine can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00612</drugbank-id>
      <name>Bisoprolol</name>
      <description>The serum concentration of Bisoprolol can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00619</drugbank-id>
      <name>Imatinib</name>
      <description>The serum concentration of Imatinib can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00622</drugbank-id>
      <name>Nicardipine</name>
      <description>The serum concentration of Nicardipine can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00635</drugbank-id>
      <name>Prednisone</name>
      <description>The serum concentration of Prednisone can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00641</drugbank-id>
      <name>Simvastatin</name>
      <description>The serum concentration of Simvastatin can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00652</drugbank-id>
      <name>Pentazocine</name>
      <description>The serum concentration of Pentazocine can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00661</drugbank-id>
      <name>Verapamil</name>
      <description>The serum concentration of Verapamil can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00669</drugbank-id>
      <name>Sumatriptan</name>
      <description>The serum concentration of Sumatriptan can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00675</drugbank-id>
      <name>Tamoxifen</name>
      <description>The serum concentration of Tamoxifen can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00678</drugbank-id>
      <name>Losartan</name>
      <description>The serum concentration of Losartan can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00688</drugbank-id>
      <name>Mycophenolate mofetil</name>
      <description>The serum concentration of Mycophenolate mofetil can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00694</drugbank-id>
      <name>Daunorubicin</name>
      <description>The serum concentration of Daunorubicin can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00698</drugbank-id>
      <name>Nitrofurantoin</name>
      <description>The serum concentration of Nitrofurantoin can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00701</drugbank-id>
      <name>Amprenavir</name>
      <description>The serum concentration of Amprenavir can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00709</drugbank-id>
      <name>Lamivudine</name>
      <description>The serum concentration of Lamivudine can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00734</drugbank-id>
      <name>Risperidone</name>
      <description>The serum concentration of Risperidone can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00736</drugbank-id>
      <name>Esomeprazole</name>
      <description>The serum concentration of Esomeprazole can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00741</drugbank-id>
      <name>Hydrocortisone</name>
      <description>The serum concentration of Hydrocortisone can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00742</drugbank-id>
      <name>Mannitol</name>
      <description>The serum concentration of Mannitol can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00758</drugbank-id>
      <name>Clopidogrel</name>
      <description>The serum concentration of Clopidogrel can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00759</drugbank-id>
      <name>Tetracycline</name>
      <description>The serum concentration of Tetracycline can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00762</drugbank-id>
      <name>Irinotecan</name>
      <description>The serum concentration of Irinotecan can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00768</drugbank-id>
      <name>Olopatadine</name>
      <description>The serum concentration of Olopatadine can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00773</drugbank-id>
      <name>Etoposide</name>
      <description>The serum concentration of Etoposide can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00783</drugbank-id>
      <name>Estradiol</name>
      <description>The serum concentration of Estradiol can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00829</drugbank-id>
      <name>Diazepam</name>
      <description>The serum concentration of Diazepam can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00831</drugbank-id>
      <name>Trifluoperazine</name>
      <description>The serum concentration of Trifluoperazine can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00836</drugbank-id>
      <name>Loperamide</name>
      <description>The serum concentration of Loperamide can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00860</drugbank-id>
      <name>Prednisolone</name>
      <description>The serum concentration of Prednisolone can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00863</drugbank-id>
      <name>Ranitidine</name>
      <description>The serum concentration of Ranitidine can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00875</drugbank-id>
      <name>Flupentixol</name>
      <description>The serum concentration of Flupentixol can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00882</drugbank-id>
      <name>Clomifene</name>
      <description>The serum concentration of Clomifene can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00904</drugbank-id>
      <name>Ondansetron</name>
      <description>The serum concentration of Ondansetron can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00945</drugbank-id>
      <name>Acetylsalicylic acid</name>
      <description>The serum concentration of Acetylsalicylic acid can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00950</drugbank-id>
      <name>Fexofenadine</name>
      <description>The serum concentration of Fexofenadine can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00959</drugbank-id>
      <name>Methylprednisolone</name>
      <description>The serum concentration of Methylprednisolone can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00970</drugbank-id>
      <name>Dactinomycin</name>
      <description>The serum concentration of Dactinomycin can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00973</drugbank-id>
      <name>Ezetimibe</name>
      <description>The serum concentration of Ezetimibe can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00977</drugbank-id>
      <name>Ethinylestradiol</name>
      <description>The serum concentration of Ethinylestradiol can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00987</drugbank-id>
      <name>Cytarabine</name>
      <description>The serum concentration of Cytarabine can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01005</drugbank-id>
      <name>Hydroxyurea</name>
      <description>The serum concentration of Hydroxyurea can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01026</drugbank-id>
      <name>Ketoconazole</name>
      <description>The serum concentration of Ketoconazole can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01042</drugbank-id>
      <name>Melphalan</name>
      <description>The serum concentration of Melphalan can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01050</drugbank-id>
      <name>Ibuprofen</name>
      <description>The serum concentration of Ibuprofen can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01072</drugbank-id>
      <name>Atazanavir</name>
      <description>The serum concentration of Atazanavir can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01076</drugbank-id>
      <name>Atorvastatin</name>
      <description>The serum concentration of Atorvastatin can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01079</drugbank-id>
      <name>Tegaserod</name>
      <description>The serum concentration of Tegaserod can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01115</drugbank-id>
      <name>Nifedipine</name>
      <description>The serum concentration of Nifedipine can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01137</drugbank-id>
      <name>Levofloxacin</name>
      <description>The serum concentration of Levofloxacin can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01142</drugbank-id>
      <name>Doxepin</name>
      <description>The serum concentration of Doxepin can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01167</drugbank-id>
      <name>Itraconazole</name>
      <description>The serum concentration of Itraconazole can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01169</drugbank-id>
      <name>Arsenic trioxide</name>
      <description>The serum concentration of Arsenic trioxide can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01183</drugbank-id>
      <name>Naloxone</name>
      <description>The serum concentration of Naloxone can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01184</drugbank-id>
      <name>Domperidone</name>
      <description>The serum concentration of Domperidone can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01193</drugbank-id>
      <name>Acebutolol</name>
      <description>The serum concentration of Acebutolol can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01200</drugbank-id>
      <name>Bromocriptine</name>
      <description>The serum concentration of Bromocriptine can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01202</drugbank-id>
      <name>Levetiracetam</name>
      <description>The serum concentration of Levetiracetam can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01203</drugbank-id>
      <name>Nadolol</name>
      <description>The serum concentration of Nadolol can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01204</drugbank-id>
      <name>Mitoxantrone</name>
      <description>The serum concentration of Mitoxantrone can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01208</drugbank-id>
      <name>Sparfloxacin</name>
      <description>The serum concentration of Sparfloxacin can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01211</drugbank-id>
      <name>Clarithromycin</name>
      <description>The serum concentration of Clarithromycin can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01224</drugbank-id>
      <name>Quetiapine</name>
      <description>The serum concentration of Quetiapine can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01232</drugbank-id>
      <name>Saquinavir</name>
      <description>The serum concentration of Saquinavir can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01234</drugbank-id>
      <name>Dexamethasone</name>
      <description>The serum concentration of Dexamethasone can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01248</drugbank-id>
      <name>Docetaxel</name>
      <description>The serum concentration of Docetaxel can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01254</drugbank-id>
      <name>Dasatinib</name>
      <description>The serum concentration of Dasatinib can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01261</drugbank-id>
      <name>Sitagliptin</name>
      <description>The serum concentration of Sitagliptin can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01263</drugbank-id>
      <name>Posaconazole</name>
      <description>The serum concentration of Posaconazole can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01267</drugbank-id>
      <name>Paliperidone</name>
      <description>The serum concentration of Paliperidone can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01268</drugbank-id>
      <name>Sunitinib</name>
      <description>The serum concentration of Sunitinib can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01339</drugbank-id>
      <name>Vecuronium</name>
      <description>The serum concentration of Vecuronium can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01400</drugbank-id>
      <name>Neostigmine</name>
      <description>The serum concentration of Neostigmine can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01420</drugbank-id>
      <name>Testosterone propionate</name>
      <description>The serum concentration of Testosterone propionate can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01587</drugbank-id>
      <name>Ketazolam</name>
      <description>The serum concentration of Ketazolam can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB02901</drugbank-id>
      <name>Stanolone</name>
      <description>The serum concentration of Stanolone can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB03203</drugbank-id>
      <name>Sphingosine</name>
      <description>The serum concentration of Sphingosine can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB03825</drugbank-id>
      <name>Rhodamine 6G</name>
      <description>The serum concentration of Rhodamine 6G can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04348</drugbank-id>
      <name>Taurocholic acid</name>
      <description>The serum concentration of Taurocholic acid can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04573</drugbank-id>
      <name>Estriol</name>
      <description>The serum concentration of Estriol can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04630</drugbank-id>
      <name>Aldosterone</name>
      <description>The serum concentration of Aldosterone can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04690</drugbank-id>
      <name>Camptothecin</name>
      <description>The serum concentration of Camptothecin can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04840</drugbank-id>
      <name>Debrisoquine</name>
      <description>The serum concentration of Debrisoquine can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04846</drugbank-id>
      <name>Celiprolol</name>
      <description>The serum concentration of Celiprolol can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04868</drugbank-id>
      <name>Nilotinib</name>
      <description>The serum concentration of Nilotinib can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05015</drugbank-id>
      <name>Belinostat</name>
      <description>The serum concentration of Belinostat can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05039</drugbank-id>
      <name>Indacaterol</name>
      <description>The serum concentration of Indacaterol can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05239</drugbank-id>
      <name>Cobimetinib</name>
      <description>The serum concentration of Cobimetinib can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05521</drugbank-id>
      <name>Telaprevir</name>
      <description>The serum concentration of Telaprevir can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05773</drugbank-id>
      <name>Trastuzumab emtansine</name>
      <description>The serum concentration of Trastuzumab emtansine can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05889</drugbank-id>
      <name>Inotuzumab ozogamicin</name>
      <description>The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06176</drugbank-id>
      <name>Romidepsin</name>
      <description>The serum concentration of Romidepsin can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06212</drugbank-id>
      <name>Tolvaptan</name>
      <description>The serum concentration of Tolvaptan can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06228</drugbank-id>
      <name>Rivaroxaban</name>
      <description>The serum concentration of Rivaroxaban can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06290</drugbank-id>
      <name>Simeprevir</name>
      <description>The serum concentration of Simeprevir can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06292</drugbank-id>
      <name>Dapagliflozin</name>
      <description>The serum concentration of Dapagliflozin can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06403</drugbank-id>
      <name>Ambrisentan</name>
      <description>The serum concentration of Ambrisentan can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06603</drugbank-id>
      <name>Panobinostat</name>
      <description>The serum concentration of Panobinostat can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06605</drugbank-id>
      <name>Apixaban</name>
      <description>The serum concentration of Apixaban can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06626</drugbank-id>
      <name>Axitinib</name>
      <description>The serum concentration of Axitinib can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06670</drugbank-id>
      <name>Odanacatib</name>
      <description>The serum concentration of Odanacatib can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06702</drugbank-id>
      <name>Fesoterodine</name>
      <description>The serum concentration of Fesoterodine can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06772</drugbank-id>
      <name>Cabazitaxel</name>
      <description>The serum concentration of Cabazitaxel can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08816</drugbank-id>
      <name>Ticagrelor</name>
      <description>The serum concentration of Ticagrelor can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08828</drugbank-id>
      <name>Vismodegib</name>
      <description>The serum concentration of Vismodegib can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08860</drugbank-id>
      <name>Pitavastatin</name>
      <description>The serum concentration of Pitavastatin can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08865</drugbank-id>
      <name>Crizotinib</name>
      <description>The serum concentration of Crizotinib can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08874</drugbank-id>
      <name>Fidaxomicin</name>
      <description>The serum concentration of Fidaxomicin can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08881</drugbank-id>
      <name>Vemurafenib</name>
      <description>The serum concentration of Vemurafenib can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08882</drugbank-id>
      <name>Linagliptin</name>
      <description>The serum concentration of Linagliptin can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08889</drugbank-id>
      <name>Carfilzomib</name>
      <description>The serum concentration of Carfilzomib can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08893</drugbank-id>
      <name>Mirabegron</name>
      <description>The serum concentration of Mirabegron can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08896</drugbank-id>
      <name>Regorafenib</name>
      <description>The serum concentration of Regorafenib can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08901</drugbank-id>
      <name>Ponatinib</name>
      <description>The serum concentration of Ponatinib can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08906</drugbank-id>
      <name>Fluticasone furoate</name>
      <description>The serum concentration of Fluticasone furoate can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08907</drugbank-id>
      <name>Canagliflozin</name>
      <description>The serum concentration of Canagliflozin can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08910</drugbank-id>
      <name>Pomalidomide</name>
      <description>The serum concentration of Pomalidomide can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08912</drugbank-id>
      <name>Dabrafenib</name>
      <description>The serum concentration of Dabrafenib can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08918</drugbank-id>
      <name>Levomilnacipran</name>
      <description>The serum concentration of Levomilnacipran can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08930</drugbank-id>
      <name>Dolutegravir</name>
      <description>The serum concentration of Dolutegravir can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08934</drugbank-id>
      <name>Sofosbuvir</name>
      <description>The serum concentration of Sofosbuvir can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09054</drugbank-id>
      <name>Idelalisib</name>
      <description>The serum concentration of Idelalisib can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09063</drugbank-id>
      <name>Ceritinib</name>
      <description>The serum concentration of Ceritinib can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09073</drugbank-id>
      <name>Palbociclib</name>
      <description>The serum concentration of Palbociclib can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09074</drugbank-id>
      <name>Olaparib</name>
      <description>The serum concentration of Olaparib can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09076</drugbank-id>
      <name>Umeclidinium</name>
      <description>The serum concentration of Umeclidinium can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09078</drugbank-id>
      <name>Lenvatinib</name>
      <description>The serum concentration of Lenvatinib can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09079</drugbank-id>
      <name>Nintedanib</name>
      <description>The serum concentration of Nintedanib can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09099</drugbank-id>
      <name>Somatostatin</name>
      <description>The serum concentration of Somatostatin can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09161</drugbank-id>
      <name>Technetium Tc-99m sestamibi</name>
      <description>The serum concentration of Technetium Tc-99m sestamibi can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09183</drugbank-id>
      <name>Dasabuvir</name>
      <description>The serum concentration of Dasabuvir can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09270</drugbank-id>
      <name>Ubidecarenone</name>
      <description>The serum concentration of Ubidecarenone can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09296</drugbank-id>
      <name>Ombitasvir</name>
      <description>The serum concentration of Ombitasvir can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09297</drugbank-id>
      <name>Paritaprevir</name>
      <description>The serum concentration of Paritaprevir can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09299</drugbank-id>
      <name>Tenofovir alafenamide</name>
      <description>The serum concentration of Tenofovir alafenamide can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09330</drugbank-id>
      <name>Osimertinib</name>
      <description>The serum concentration of Osimertinib can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11362</drugbank-id>
      <name>Selexipag</name>
      <description>The serum concentration of Selexipag can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11431</drugbank-id>
      <name>Moxidectin</name>
      <description>The serum concentration of Moxidectin can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11447</drugbank-id>
      <name>Phenothiazine</name>
      <description>The serum concentration of Phenothiazine can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11574</drugbank-id>
      <name>Elbasvir</name>
      <description>The serum concentration of Elbasvir can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11575</drugbank-id>
      <name>Grazoprevir</name>
      <description>The serum concentration of Grazoprevir can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11581</drugbank-id>
      <name>Venetoclax</name>
      <description>The serum concentration of Venetoclax can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11586</drugbank-id>
      <name>Asunaprevir</name>
      <description>The serum concentration of Asunaprevir can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11613</drugbank-id>
      <name>Velpatasvir</name>
      <description>The serum concentration of Velpatasvir can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11641</drugbank-id>
      <name>Vinflunine</name>
      <description>The serum concentration of Vinflunine can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11672</drugbank-id>
      <name>Curcumin</name>
      <description>The serum concentration of Curcumin can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11712</drugbank-id>
      <name>Tezacaftor</name>
      <description>The serum concentration of Tezacaftor can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11753</drugbank-id>
      <name>Rifamycin</name>
      <description>The serum concentration of Rifamycin can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11760</drugbank-id>
      <name>Talazoparib</name>
      <description>The serum concentration of Talazoparib can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11770</drugbank-id>
      <name>Talinolol</name>
      <description>The serum concentration of Talinolol can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11817</drugbank-id>
      <name>Baricitinib</name>
      <description>The serum concentration of Baricitinib can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11827</drugbank-id>
      <name>Ertugliflozin</name>
      <description>The serum concentration of Ertugliflozin can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11855</drugbank-id>
      <name>Revefenacin</name>
      <description>The serum concentration of Revefenacin can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11869</drugbank-id>
      <name>Valspodar</name>
      <description>The serum concentration of Valspodar can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11952</drugbank-id>
      <name>Duvelisib</name>
      <description>The serum concentration of Duvelisib can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11963</drugbank-id>
      <name>Dacomitinib</name>
      <description>The serum concentration of Dacomitinib can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11978</drugbank-id>
      <name>Glasdegib</name>
      <description>The serum concentration of Glasdegib can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11979</drugbank-id>
      <name>Elagolix</name>
      <description>The serum concentration of Elagolix can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11995</drugbank-id>
      <name>Avatrombopag</name>
      <description>The serum concentration of Avatrombopag can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12001</drugbank-id>
      <name>Abemaciclib</name>
      <description>The serum concentration of Abemaciclib can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12015</drugbank-id>
      <name>Alpelisib</name>
      <description>The serum concentration of Alpelisib can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12026</drugbank-id>
      <name>Voxilaprevir</name>
      <description>The serum concentration of Voxilaprevir can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12070</drugbank-id>
      <name>Letermovir</name>
      <description>The serum concentration of Letermovir can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12141</drugbank-id>
      <name>Gilteritinib</name>
      <description>The serum concentration of Gilteritinib can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12147</drugbank-id>
      <name>Erdafitinib</name>
      <description>The serum concentration of Erdafitinib can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12332</drugbank-id>
      <name>Rucaparib</name>
      <description>The serum concentration of Rucaparib can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12401</drugbank-id>
      <name>Bromperidol</name>
      <description>The serum concentration of Bromperidol can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12455</drugbank-id>
      <name>Omadacycline</name>
      <description>The serum concentration of Omadacycline can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12483</drugbank-id>
      <name>Copanlisib</name>
      <description>The serum concentration of Copanlisib can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12836</drugbank-id>
      <name>Grapiprant</name>
      <description>The serum concentration of Grapiprant can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13125</drugbank-id>
      <name>Lusutrombopag</name>
      <description>The serum concentration of Lusutrombopag can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13146</drugbank-id>
      <name>Fluciclovine (18F)</name>
      <description>The serum concentration of Fluciclovine (18F) can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13173</drugbank-id>
      <name>Cerliponase alfa</name>
      <description>The serum concentration of Cerliponase alfa can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13867</drugbank-id>
      <name>Fluticasone</name>
      <description>The serum concentration of Fluticasone can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13878</drugbank-id>
      <name>Pibrentasvir</name>
      <description>The serum concentration of Pibrentasvir can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13879</drugbank-id>
      <name>Glecaprevir</name>
      <description>The serum concentration of Glecaprevir can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13951</drugbank-id>
      <name>Stanolone acetate</name>
      <description>The serum concentration of Stanolone acetate can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13952</drugbank-id>
      <name>Estradiol acetate</name>
      <description>The serum concentration of Estradiol acetate can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13953</drugbank-id>
      <name>Estradiol benzoate</name>
      <description>The serum concentration of Estradiol benzoate can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13954</drugbank-id>
      <name>Estradiol cypionate</name>
      <description>The serum concentration of Estradiol cypionate can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13955</drugbank-id>
      <name>Estradiol dienanthate</name>
      <description>The serum concentration of Estradiol dienanthate can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13956</drugbank-id>
      <name>Estradiol valerate</name>
      <description>The serum concentration of Estradiol valerate can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14057</drugbank-id>
      <name>Valinomycin</name>
      <description>The serum concentration of Valinomycin can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14126</drugbank-id>
      <name>Tenofovir</name>
      <description>The serum concentration of Tenofovir can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14568</drugbank-id>
      <name>Ivosidenib</name>
      <description>The serum concentration of Ivosidenib can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14723</drugbank-id>
      <name>Larotrectinib</name>
      <description>The serum concentration of Larotrectinib can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00843</drugbank-id>
      <name>Donepezil</name>
      <description>The serum concentration of Donepezil can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11986</drugbank-id>
      <name>Entrectinib</name>
      <description>The serum concentration of Entrectinib can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12500</drugbank-id>
      <name>Fedratinib</name>
      <description>The serum concentration of Fedratinib can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01222</drugbank-id>
      <name>Budesonide</name>
      <description>The serum concentration of Budesonide can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01233</drugbank-id>
      <name>Metoclopramide</name>
      <description>The serum concentration of Metoclopramide can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00455</drugbank-id>
      <name>Loratadine</name>
      <description>The serum concentration of Loratadine can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00776</drugbank-id>
      <name>Oxcarbazepine</name>
      <description>The serum concentration of Oxcarbazepine can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01195</drugbank-id>
      <name>Flecainide</name>
      <description>The serum concentration of Flecainide can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01217</drugbank-id>
      <name>Anastrozole</name>
      <description>The serum concentration of Anastrozole can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11732</drugbank-id>
      <name>Lasmiditan</name>
      <description>The serum concentration of Lasmiditan can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13007</drugbank-id>
      <name>Enfortumab vedotin</name>
      <description>The serum concentration of Enfortumab vedotin can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14962</drugbank-id>
      <name>Trastuzumab deruxtecan</name>
      <description>The serum concentration of Trastuzumab deruxtecan can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12941</drugbank-id>
      <name>Darolutamide</name>
      <description>The serum concentration of Darolutamide can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15328</drugbank-id>
      <name>Ubrogepant</name>
      <description>The serum concentration of Ubrogepant can be increased when it is combined with Sapropterin.</description>
    </drug-interaction>
  </drug-interactions>
  <calculated-properties>
    <property>
      <kind>logP</kind>
      <value>-1.8</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logS</kind>
      <value>-2.1</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>Water Solubility</kind>
      <value>2.03e+00 g/l</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>-2.3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>IUPAC Name</kind>
      <value>(6R)-2-amino-6-[(1R,2S)-1,2-dihydroxypropyl]-3,4,5,6,7,8-hexahydropteridin-4-one</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Traditional IUPAC Name</kind>
      <value>6R-5,6,7,8-tetrahydrobiopterin</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Weight</kind>
      <value>241.2471</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Monoisotopic Weight</kind>
      <value>241.117489371</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>SMILES</kind>
      <value>[H][C@@]1(CNC2=C(N1)C(=O)NC(N)=N2)[C@@H](O)[C@H](C)O</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Formula</kind>
      <value>C9H15N5O3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChI</kind>
      <value>InChI=1S/C9H15N5O3/c1-3(15)6(16)4-2-11-7-5(12-4)8(17)14-9(10)13-7/h3-4,6,12,15-16H,2H2,1H3,(H4,10,11,13,14,17)/t3-,4+,6-/m0/s1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChIKey</kind>
      <value>FNKQXYHWGSIFBK-RPDRRWSUSA-N</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polar Surface Area (PSA)</kind>
      <value>132</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Refractivity</kind>
      <value>68.63</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polarizability</kind>
      <value>23.61</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rotatable Bond Count</kind>
      <value>2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Acceptor Count</kind>
      <value>7</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Donor Count</kind>
      <value>6</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest acidic)</kind>
      <value>11.12</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest basic)</kind>
      <value>4.61</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Physiological Charge</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Number of Rings</kind>
      <value>2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Bioavailability</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rule of Five</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Ghose Filter</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>MDDR-Like Rule</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
  </calculated-properties>
  <experimental-properties>
    <property>
      <kind>Water Solubility</kind>
      <value>&gt;20 mg/mL (dichloride salt)</value>
      <source/>
    </property>
    <property>
      <kind>Melting Point</kind>
      <value>250-255 Â°C (hydrochloride salt)</value>
      <source/>
    </property>
    <property>
      <kind>logP</kind>
      <value>-1.7</value>
      <source/>
    </property>
  </experimental-properties>
  <external-identifiers>
    <external-identifier>
      <resource>Drugs Product Database (DPD)</resource>
      <identifier>20591</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEBI</resource>
      <identifier>59560</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Compound</resource>
      <identifier>44257</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Substance</resource>
      <identifier>46508597</identifier>
    </external-identifier>
    <external-identifier>
      <resource>KEGG Compound</resource>
      <identifier>C00272</identifier>
    </external-identifier>
    <external-identifier>
      <resource>KEGG Drug</resource>
      <identifier>D08505</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChemSpider</resource>
      <identifier>40270</identifier>
    </external-identifier>
    <external-identifier>
      <resource>BindingDB</resource>
      <identifier>50373697</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PharmGKB</resource>
      <identifier>PA161990676</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PDB</resource>
      <identifier>H4B</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Therapeutic Targets Database</resource>
      <identifier>DNC000425</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Wikipedia</resource>
      <identifier>Tetrahydrobiopterin</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEMBL</resource>
      <identifier>CHEMBL1201774</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links/>
  <pathways>
    <pathway>
      <smpdb-id>SMP0000063</smpdb-id>
      <name>Tryptophan Metabolism</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00150</drugbank-id>
          <name>L-Tryptophan</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB01065</drugbank-id>
          <name>Melatonin</name>
        </drug>
        <drug>
          <drugbank-id>DB01592</drugbank-id>
          <name>Iron</name>
        </drug>
        <drug>
          <drugbank-id>DB01796</drugbank-id>
          <name>Quinolinic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01942</drugbank-id>
          <name>Formic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB02070</drugbank-id>
          <name>L-2-Amino-4-[2-Aminophenyl]-4-Oxobutanoic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB02959</drugbank-id>
          <name>Oxitriptan</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03644</drugbank-id>
          <name>3-hydroxyanthranilic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04275</drugbank-id>
          <name>N-acetylserotonin</name>
        </drug>
        <drug>
          <drugbank-id>DB07950</drugbank-id>
          <name>Indoleacetic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB08653</drugbank-id>
          <name>2-(1H-INDOL-3-YL)ETHANAMINE</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P23381</uniprot-id>
        <uniprot-id>Q9UGM6</uniprot-id>
        <uniprot-id>P48775</uniprot-id>
        <uniprot-id>Q16719</uniprot-id>
        <uniprot-id>Q63HM1</uniprot-id>
        <uniprot-id>Q8N5Z0</uniprot-id>
        <uniprot-id>O15229</uniprot-id>
        <uniprot-id>P04040</uniprot-id>
        <uniprot-id>P46952</uniprot-id>
        <uniprot-id>Q8TDX5</uniprot-id>
        <uniprot-id>P17752</uniprot-id>
        <uniprot-id>P20711</uniprot-id>
        <uniprot-id>P05091</uniprot-id>
        <uniprot-id>P46597</uniprot-id>
        <uniprot-id>P14902</uniprot-id>
        <uniprot-id>Q16613</uniprot-id>
        <uniprot-id>P04798</uniprot-id>
        <uniprot-id>O95050</uniprot-id>
        <uniprot-id>Q06278</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000362</smpdb-id>
      <name>Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00125</drugbank-id>
          <name>L-Arginine</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>Aspartic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00129</drugbank-id>
          <name>Ornithine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00148</drugbank-id>
          <name>Creatine</name>
        </drug>
        <drug>
          <drugbank-id>DB00155</drugbank-id>
          <name>L-Citrulline</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00172</drugbank-id>
          <name>Proline</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB00435</drugbank-id>
          <name>Nitric Oxide</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB02751</drugbank-id>
          <name>Glycocyamine</name>
        </drug>
        <drug>
          <drugbank-id>DB02838</drugbank-id>
          <name>3,4-Dihydro-2h-Pyrrolium-5-Carboxylate</name>
        </drug>
        <drug>
          <drugbank-id>DB03144</drugbank-id>
          <name>N-Omega-Hydroxy-L-Arginine</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03247</drugbank-id>
          <name>Flavin mononucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03904</drugbank-id>
          <name>Urea</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04388</drugbank-id>
          <name>4-Carboxy-4-Aminobutanal</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P00966</uniprot-id>
        <uniprot-id>P04424</uniprot-id>
        <uniprot-id>P31327</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>P04181</uniprot-id>
        <uniprot-id>P30038</uniprot-id>
        <uniprot-id>O43272</uniprot-id>
        <uniprot-id>Q96C36</uniprot-id>
        <uniprot-id>P07814</uniprot-id>
        <uniprot-id>Q7Z4N8</uniprot-id>
        <uniprot-id>Q5T160</uniprot-id>
        <uniprot-id>P50440</uniprot-id>
        <uniprot-id>Q14353</uniprot-id>
        <uniprot-id>P12277</uniprot-id>
        <uniprot-id>P05089</uniprot-id>
        <uniprot-id>P00480</uniprot-id>
        <uniprot-id>Q9Y619</uniprot-id>
        <uniprot-id>P14920</uniprot-id>
        <uniprot-id>P17174</uniprot-id>
        <uniprot-id>P29475</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000486</smpdb-id>
      <name>DOPA-Responsive Dystonia</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01942</drugbank-id>
          <name>Formic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB02385</drugbank-id>
          <name>D-threo-neopterin</name>
        </drug>
        <drug>
          <drugbank-id>DB03896</drugbank-id>
          <name>Triphosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P30793</uniprot-id>
        <uniprot-id>P30047</uniprot-id>
        <uniprot-id>Q03393</uniprot-id>
        <uniprot-id>P35270</uniprot-id>
        <uniprot-id>P15121</uniprot-id>
        <uniprot-id>P16152</uniprot-id>
        <uniprot-id>P00374</uniprot-id>
        <uniprot-id>P09417</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000504</smpdb-id>
      <name>Creatine Deficiency, Guanidinoacetate Methyltransferase Deficiency</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00125</drugbank-id>
          <name>L-Arginine</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>Aspartic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00129</drugbank-id>
          <name>Ornithine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00148</drugbank-id>
          <name>Creatine</name>
        </drug>
        <drug>
          <drugbank-id>DB00155</drugbank-id>
          <name>L-Citrulline</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00172</drugbank-id>
          <name>Proline</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB00435</drugbank-id>
          <name>Nitric Oxide</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB02751</drugbank-id>
          <name>Glycocyamine</name>
        </drug>
        <drug>
          <drugbank-id>DB02838</drugbank-id>
          <name>3,4-Dihydro-2h-Pyrrolium-5-Carboxylate</name>
        </drug>
        <drug>
          <drugbank-id>DB03144</drugbank-id>
          <name>N-Omega-Hydroxy-L-Arginine</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03247</drugbank-id>
          <name>Flavin mononucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03904</drugbank-id>
          <name>Urea</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04388</drugbank-id>
          <name>4-Carboxy-4-Aminobutanal</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P00966</uniprot-id>
        <uniprot-id>P04424</uniprot-id>
        <uniprot-id>P31327</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>P04181</uniprot-id>
        <uniprot-id>P30038</uniprot-id>
        <uniprot-id>O43272</uniprot-id>
        <uniprot-id>Q96C36</uniprot-id>
        <uniprot-id>P07814</uniprot-id>
        <uniprot-id>Q7Z4N8</uniprot-id>
        <uniprot-id>Q5T160</uniprot-id>
        <uniprot-id>P50440</uniprot-id>
        <uniprot-id>Q14353</uniprot-id>
        <uniprot-id>P12277</uniprot-id>
        <uniprot-id>P05089</uniprot-id>
        <uniprot-id>P00480</uniprot-id>
        <uniprot-id>Q9Y619</uniprot-id>
        <uniprot-id>P14920</uniprot-id>
        <uniprot-id>P17174</uniprot-id>
        <uniprot-id>P29475</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000505</smpdb-id>
      <name>Hyperornithinemia with Gyrate Atrophy (HOGA)</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00125</drugbank-id>
          <name>L-Arginine</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>Aspartic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00129</drugbank-id>
          <name>Ornithine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00148</drugbank-id>
          <name>Creatine</name>
        </drug>
        <drug>
          <drugbank-id>DB00155</drugbank-id>
          <name>L-Citrulline</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00172</drugbank-id>
          <name>Proline</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB00435</drugbank-id>
          <name>Nitric Oxide</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB02751</drugbank-id>
          <name>Glycocyamine</name>
        </drug>
        <drug>
          <drugbank-id>DB02838</drugbank-id>
          <name>3,4-Dihydro-2h-Pyrrolium-5-Carboxylate</name>
        </drug>
        <drug>
          <drugbank-id>DB03144</drugbank-id>
          <name>N-Omega-Hydroxy-L-Arginine</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03247</drugbank-id>
          <name>Flavin mononucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03904</drugbank-id>
          <name>Urea</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04388</drugbank-id>
          <name>4-Carboxy-4-Aminobutanal</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P00966</uniprot-id>
        <uniprot-id>P04424</uniprot-id>
        <uniprot-id>P31327</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>P04181</uniprot-id>
        <uniprot-id>P30038</uniprot-id>
        <uniprot-id>O43272</uniprot-id>
        <uniprot-id>Q96C36</uniprot-id>
        <uniprot-id>P07814</uniprot-id>
        <uniprot-id>Q7Z4N8</uniprot-id>
        <uniprot-id>Q5T160</uniprot-id>
        <uniprot-id>P50440</uniprot-id>
        <uniprot-id>Q14353</uniprot-id>
        <uniprot-id>P12277</uniprot-id>
        <uniprot-id>P05089</uniprot-id>
        <uniprot-id>P00480</uniprot-id>
        <uniprot-id>Q9Y619</uniprot-id>
        <uniprot-id>P14920</uniprot-id>
        <uniprot-id>P17174</uniprot-id>
        <uniprot-id>P29475</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000650</smpdb-id>
      <name>Doxorubicin Metabolism Pathway</name>
      <category>drug_metabolism</category>
      <drugs>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB00997</drugbank-id>
          <name>Doxorubicin</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03247</drugbank-id>
          <name>Flavin mononucleotide</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>Q86VW1</uniprot-id>
        <uniprot-id>P15559</uniprot-id>
        <uniprot-id>P16435</uniprot-id>
        <uniprot-id>P47989</uniprot-id>
        <uniprot-id>P08183</uniprot-id>
        <uniprot-id>P33527</uniprot-id>
        <uniprot-id>Q92887</uniprot-id>
        <uniprot-id>Q9UNQ0</uniprot-id>
        <uniprot-id>Q15311</uniprot-id>
        <uniprot-id>P16152</uniprot-id>
        <uniprot-id>O75828</uniprot-id>
        <uniprot-id>P42330</uniprot-id>
        <uniprot-id>P14550</uniprot-id>
        <uniprot-id>P29474</uniprot-id>
        <uniprot-id>O75306</uniprot-id>
        <uniprot-id>O75489</uniprot-id>
        <uniprot-id>O75251</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000006</smpdb-id>
      <name>Tyrosine Metabolism</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00126</drugbank-id>
          <name>Ascorbic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>Aspartic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00135</drugbank-id>
          <name>Tyrosine</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB00368</drugbank-id>
          <name>Norepinephrine</name>
        </drug>
        <drug>
          <drugbank-id>DB00668</drugbank-id>
          <name>Epinephrine</name>
        </drug>
        <drug>
          <drugbank-id>DB00988</drugbank-id>
          <name>Dopamine</name>
        </drug>
        <drug>
          <drugbank-id>DB01235</drugbank-id>
          <name>Levodopa</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium cation</name>
        </drug>
        <drug>
          <drugbank-id>DB01592</drugbank-id>
          <name>Iron</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01702</drugbank-id>
          <name>2-(3,4-Dihydroxyphenyl)Acetic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01762</drugbank-id>
          <name>Acetoacetic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01828</drugbank-id>
          <name>Methylamine</name>
        </drug>
        <drug>
          <drugbank-id>DB02232</drugbank-id>
          <name>1,2-Dihydroxybenzene</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03205</drugbank-id>
          <name>Pyrroloquinoline Quinone</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB07718</drugbank-id>
          <name>3-(4-HYDROXY-PHENYL)PYRUVIC ACID</name>
        </drug>
        <drug>
          <drugbank-id>DB08327</drugbank-id>
          <name>2-(3,6-DIHYDROXYPHENYL)ACETIC ACID</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P17735</uniprot-id>
        <uniprot-id>P17174</uniprot-id>
        <uniprot-id>P32754</uniprot-id>
        <uniprot-id>O43708</uniprot-id>
        <uniprot-id>P16930</uniprot-id>
        <uniprot-id>P20711</uniprot-id>
        <uniprot-id>P30838</uniprot-id>
        <uniprot-id>P14679</uniprot-id>
        <uniprot-id>P09172</uniprot-id>
        <uniprot-id>P40126</uniprot-id>
        <uniprot-id>P11086</uniprot-id>
        <uniprot-id>P21397</uniprot-id>
        <uniprot-id>P07327</uniprot-id>
        <uniprot-id>Q93099</uniprot-id>
        <uniprot-id>P14174</uniprot-id>
        <uniprot-id>P19801</uniprot-id>
        <uniprot-id>P21964</uniprot-id>
        <uniprot-id>P46952</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000020</smpdb-id>
      <name>Arginine and Proline Metabolism</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00125</drugbank-id>
          <name>L-Arginine</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>Aspartic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00129</drugbank-id>
          <name>Ornithine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00148</drugbank-id>
          <name>Creatine</name>
        </drug>
        <drug>
          <drugbank-id>DB00155</drugbank-id>
          <name>L-Citrulline</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00172</drugbank-id>
          <name>Proline</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB00435</drugbank-id>
          <name>Nitric Oxide</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB02751</drugbank-id>
          <name>Glycocyamine</name>
        </drug>
        <drug>
          <drugbank-id>DB02838</drugbank-id>
          <name>3,4-Dihydro-2h-Pyrrolium-5-Carboxylate</name>
        </drug>
        <drug>
          <drugbank-id>DB03144</drugbank-id>
          <name>N-Omega-Hydroxy-L-Arginine</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03247</drugbank-id>
          <name>Flavin mononucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03904</drugbank-id>
          <name>Urea</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04388</drugbank-id>
          <name>4-Carboxy-4-Aminobutanal</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P00966</uniprot-id>
        <uniprot-id>P04424</uniprot-id>
        <uniprot-id>P31327</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>P04181</uniprot-id>
        <uniprot-id>P30038</uniprot-id>
        <uniprot-id>O43272</uniprot-id>
        <uniprot-id>Q96C36</uniprot-id>
        <uniprot-id>P07814</uniprot-id>
        <uniprot-id>Q7Z4N8</uniprot-id>
        <uniprot-id>Q5T160</uniprot-id>
        <uniprot-id>P50440</uniprot-id>
        <uniprot-id>Q14353</uniprot-id>
        <uniprot-id>P12277</uniprot-id>
        <uniprot-id>P05089</uniprot-id>
        <uniprot-id>P00480</uniprot-id>
        <uniprot-id>Q9Y619</uniprot-id>
        <uniprot-id>P14920</uniprot-id>
        <uniprot-id>P17174</uniprot-id>
        <uniprot-id>P29475</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000188</smpdb-id>
      <name>Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00125</drugbank-id>
          <name>L-Arginine</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>Aspartic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00129</drugbank-id>
          <name>Ornithine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00148</drugbank-id>
          <name>Creatine</name>
        </drug>
        <drug>
          <drugbank-id>DB00155</drugbank-id>
          <name>L-Citrulline</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00172</drugbank-id>
          <name>Proline</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB00435</drugbank-id>
          <name>Nitric Oxide</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB02751</drugbank-id>
          <name>Glycocyamine</name>
        </drug>
        <drug>
          <drugbank-id>DB02838</drugbank-id>
          <name>3,4-Dihydro-2h-Pyrrolium-5-Carboxylate</name>
        </drug>
        <drug>
          <drugbank-id>DB03144</drugbank-id>
          <name>N-Omega-Hydroxy-L-Arginine</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03247</drugbank-id>
          <name>Flavin mononucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03904</drugbank-id>
          <name>Urea</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04388</drugbank-id>
          <name>4-Carboxy-4-Aminobutanal</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P00966</uniprot-id>
        <uniprot-id>P04424</uniprot-id>
        <uniprot-id>P31327</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>P04181</uniprot-id>
        <uniprot-id>P30038</uniprot-id>
        <uniprot-id>O43272</uniprot-id>
        <uniprot-id>Q96C36</uniprot-id>
        <uniprot-id>P07814</uniprot-id>
        <uniprot-id>Q7Z4N8</uniprot-id>
        <uniprot-id>Q5T160</uniprot-id>
        <uniprot-id>P50440</uniprot-id>
        <uniprot-id>Q14353</uniprot-id>
        <uniprot-id>P12277</uniprot-id>
        <uniprot-id>P05089</uniprot-id>
        <uniprot-id>P00480</uniprot-id>
        <uniprot-id>Q9Y619</uniprot-id>
        <uniprot-id>P14920</uniprot-id>
        <uniprot-id>P17174</uniprot-id>
        <uniprot-id>P29475</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000218</smpdb-id>
      <name>Tyrosinemia Type I</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00126</drugbank-id>
          <name>Ascorbic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>Aspartic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00135</drugbank-id>
          <name>Tyrosine</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB00368</drugbank-id>
          <name>Norepinephrine</name>
        </drug>
        <drug>
          <drugbank-id>DB00668</drugbank-id>
          <name>Epinephrine</name>
        </drug>
        <drug>
          <drugbank-id>DB00988</drugbank-id>
          <name>Dopamine</name>
        </drug>
        <drug>
          <drugbank-id>DB01235</drugbank-id>
          <name>Levodopa</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium cation</name>
        </drug>
        <drug>
          <drugbank-id>DB01592</drugbank-id>
          <name>Iron</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01702</drugbank-id>
          <name>2-(3,4-Dihydroxyphenyl)Acetic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01762</drugbank-id>
          <name>Acetoacetic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01828</drugbank-id>
          <name>Methylamine</name>
        </drug>
        <drug>
          <drugbank-id>DB02232</drugbank-id>
          <name>1,2-Dihydroxybenzene</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03205</drugbank-id>
          <name>Pyrroloquinoline Quinone</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB07718</drugbank-id>
          <name>3-(4-HYDROXY-PHENYL)PYRUVIC ACID</name>
        </drug>
        <drug>
          <drugbank-id>DB08327</drugbank-id>
          <name>2-(3,6-DIHYDROXYPHENYL)ACETIC ACID</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P17735</uniprot-id>
        <uniprot-id>P17174</uniprot-id>
        <uniprot-id>P32754</uniprot-id>
        <uniprot-id>O43708</uniprot-id>
        <uniprot-id>P16930</uniprot-id>
        <uniprot-id>P20711</uniprot-id>
        <uniprot-id>P30838</uniprot-id>
        <uniprot-id>P14679</uniprot-id>
        <uniprot-id>P09172</uniprot-id>
        <uniprot-id>P40126</uniprot-id>
        <uniprot-id>P11086</uniprot-id>
        <uniprot-id>P21397</uniprot-id>
        <uniprot-id>P07327</uniprot-id>
        <uniprot-id>Q93099</uniprot-id>
        <uniprot-id>P14174</uniprot-id>
        <uniprot-id>P19801</uniprot-id>
        <uniprot-id>P21964</uniprot-id>
        <uniprot-id>P46952</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000360</smpdb-id>
      <name>Hyperprolinemia Type II</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00125</drugbank-id>
          <name>L-Arginine</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>Aspartic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00129</drugbank-id>
          <name>Ornithine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00148</drugbank-id>
          <name>Creatine</name>
        </drug>
        <drug>
          <drugbank-id>DB00155</drugbank-id>
          <name>L-Citrulline</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00172</drugbank-id>
          <name>Proline</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB00435</drugbank-id>
          <name>Nitric Oxide</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB02751</drugbank-id>
          <name>Glycocyamine</name>
        </drug>
        <drug>
          <drugbank-id>DB02838</drugbank-id>
          <name>3,4-Dihydro-2h-Pyrrolium-5-Carboxylate</name>
        </drug>
        <drug>
          <drugbank-id>DB03144</drugbank-id>
          <name>N-Omega-Hydroxy-L-Arginine</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03247</drugbank-id>
          <name>Flavin mononucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03904</drugbank-id>
          <name>Urea</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04388</drugbank-id>
          <name>4-Carboxy-4-Aminobutanal</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P00966</uniprot-id>
        <uniprot-id>P04424</uniprot-id>
        <uniprot-id>P31327</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>P04181</uniprot-id>
        <uniprot-id>P30038</uniprot-id>
        <uniprot-id>O43272</uniprot-id>
        <uniprot-id>Q96C36</uniprot-id>
        <uniprot-id>P07814</uniprot-id>
        <uniprot-id>Q7Z4N8</uniprot-id>
        <uniprot-id>Q5T160</uniprot-id>
        <uniprot-id>P50440</uniprot-id>
        <uniprot-id>Q14353</uniprot-id>
        <uniprot-id>P12277</uniprot-id>
        <uniprot-id>P05089</uniprot-id>
        <uniprot-id>P00480</uniprot-id>
        <uniprot-id>Q9Y619</uniprot-id>
        <uniprot-id>P14920</uniprot-id>
        <uniprot-id>P17174</uniprot-id>
        <uniprot-id>P29475</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000361</smpdb-id>
      <name>Hyperprolinemia Type I</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00125</drugbank-id>
          <name>L-Arginine</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>Aspartic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00129</drugbank-id>
          <name>Ornithine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00148</drugbank-id>
          <name>Creatine</name>
        </drug>
        <drug>
          <drugbank-id>DB00155</drugbank-id>
          <name>L-Citrulline</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00172</drugbank-id>
          <name>Proline</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB00435</drugbank-id>
          <name>Nitric Oxide</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB02751</drugbank-id>
          <name>Glycocyamine</name>
        </drug>
        <drug>
          <drugbank-id>DB02838</drugbank-id>
          <name>3,4-Dihydro-2h-Pyrrolium-5-Carboxylate</name>
        </drug>
        <drug>
          <drugbank-id>DB03144</drugbank-id>
          <name>N-Omega-Hydroxy-L-Arginine</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03247</drugbank-id>
          <name>Flavin mononucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03904</drugbank-id>
          <name>Urea</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04388</drugbank-id>
          <name>4-Carboxy-4-Aminobutanal</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P00966</uniprot-id>
        <uniprot-id>P04424</uniprot-id>
        <uniprot-id>P31327</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>P04181</uniprot-id>
        <uniprot-id>P30038</uniprot-id>
        <uniprot-id>O43272</uniprot-id>
        <uniprot-id>Q96C36</uniprot-id>
        <uniprot-id>P07814</uniprot-id>
        <uniprot-id>Q7Z4N8</uniprot-id>
        <uniprot-id>Q5T160</uniprot-id>
        <uniprot-id>P50440</uniprot-id>
        <uniprot-id>Q14353</uniprot-id>
        <uniprot-id>P12277</uniprot-id>
        <uniprot-id>P05089</uniprot-id>
        <uniprot-id>P00480</uniprot-id>
        <uniprot-id>Q9Y619</uniprot-id>
        <uniprot-id>P14920</uniprot-id>
        <uniprot-id>P17174</uniprot-id>
        <uniprot-id>P29475</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000429</smpdb-id>
      <name>Disulfiram Action Pathway</name>
      <category>drug_action</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00126</drugbank-id>
          <name>Ascorbic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>Aspartic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00135</drugbank-id>
          <name>Tyrosine</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB00368</drugbank-id>
          <name>Norepinephrine</name>
        </drug>
        <drug>
          <drugbank-id>DB00668</drugbank-id>
          <name>Epinephrine</name>
        </drug>
        <drug>
          <drugbank-id>DB00822</drugbank-id>
          <name>Disulfiram</name>
        </drug>
        <drug>
          <drugbank-id>DB00898</drugbank-id>
          <name>Ethanol</name>
        </drug>
        <drug>
          <drugbank-id>DB00988</drugbank-id>
          <name>Dopamine</name>
        </drug>
        <drug>
          <drugbank-id>DB01235</drugbank-id>
          <name>Levodopa</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium cation</name>
        </drug>
        <drug>
          <drugbank-id>DB01592</drugbank-id>
          <name>Iron</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01702</drugbank-id>
          <name>2-(3,4-Dihydroxyphenyl)Acetic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01762</drugbank-id>
          <name>Acetoacetic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01828</drugbank-id>
          <name>Methylamine</name>
        </drug>
        <drug>
          <drugbank-id>DB02232</drugbank-id>
          <name>1,2-Dihydroxybenzene</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03166</drugbank-id>
          <name>Acetic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03205</drugbank-id>
          <name>Pyrroloquinoline Quinone</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB07718</drugbank-id>
          <name>3-(4-HYDROXY-PHENYL)PYRUVIC ACID</name>
        </drug>
        <drug>
          <drugbank-id>DB08327</drugbank-id>
          <name>2-(3,6-DIHYDROXYPHENYL)ACETIC ACID</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P09172</uniprot-id>
        <uniprot-id>P30837</uniprot-id>
        <uniprot-id>P17735</uniprot-id>
        <uniprot-id>P17174</uniprot-id>
        <uniprot-id>P32754</uniprot-id>
        <uniprot-id>O43708</uniprot-id>
        <uniprot-id>P16930</uniprot-id>
        <uniprot-id>P20711</uniprot-id>
        <uniprot-id>P30838</uniprot-id>
        <uniprot-id>P14679</uniprot-id>
        <uniprot-id>P40126</uniprot-id>
        <uniprot-id>P11086</uniprot-id>
        <uniprot-id>P21397</uniprot-id>
        <uniprot-id>P07327</uniprot-id>
        <uniprot-id>Q93099</uniprot-id>
        <uniprot-id>P14174</uniprot-id>
        <uniprot-id>P19801</uniprot-id>
        <uniprot-id>P21964</uniprot-id>
        <uniprot-id>P46952</uniprot-id>
        <uniprot-id>P00325</uniprot-id>
        <uniprot-id>P05091</uniprot-id>
        <uniprot-id>P05181</uniprot-id>
        <uniprot-id>P04040</uniprot-id>
        <uniprot-id>Q9NR19</uniprot-id>
        <uniprot-id>Q9NUB1</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000487</smpdb-id>
      <name>Hyperphenylalaniemia Due to Guanosine Triphosphate Cyclohydrolase Deficiency</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01942</drugbank-id>
          <name>Formic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB02385</drugbank-id>
          <name>D-threo-neopterin</name>
        </drug>
        <drug>
          <drugbank-id>DB03896</drugbank-id>
          <name>Triphosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P30793</uniprot-id>
        <uniprot-id>P30047</uniprot-id>
        <uniprot-id>Q03393</uniprot-id>
        <uniprot-id>P35270</uniprot-id>
        <uniprot-id>P15121</uniprot-id>
        <uniprot-id>P16152</uniprot-id>
        <uniprot-id>P00374</uniprot-id>
        <uniprot-id>P09417</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000488</smpdb-id>
      <name>Hyperphenylalaninemia Due to 6-Pyruvoyltetrahydropterin Synthase Deficiency (ptps)</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01942</drugbank-id>
          <name>Formic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB02385</drugbank-id>
          <name>D-threo-neopterin</name>
        </drug>
        <drug>
          <drugbank-id>DB03896</drugbank-id>
          <name>Triphosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P30793</uniprot-id>
        <uniprot-id>P30047</uniprot-id>
        <uniprot-id>Q03393</uniprot-id>
        <uniprot-id>P35270</uniprot-id>
        <uniprot-id>P15121</uniprot-id>
        <uniprot-id>P16152</uniprot-id>
        <uniprot-id>P00374</uniprot-id>
        <uniprot-id>P09417</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000507</smpdb-id>
      <name>L-Arginine:Glycine Amidinotransferase Deficiency</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00125</drugbank-id>
          <name>L-Arginine</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>Aspartic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00129</drugbank-id>
          <name>Ornithine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00148</drugbank-id>
          <name>Creatine</name>
        </drug>
        <drug>
          <drugbank-id>DB00155</drugbank-id>
          <name>L-Citrulline</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00172</drugbank-id>
          <name>Proline</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB00435</drugbank-id>
          <name>Nitric Oxide</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB02751</drugbank-id>
          <name>Glycocyamine</name>
        </drug>
        <drug>
          <drugbank-id>DB02838</drugbank-id>
          <name>3,4-Dihydro-2h-Pyrrolium-5-Carboxylate</name>
        </drug>
        <drug>
          <drugbank-id>DB03144</drugbank-id>
          <name>N-Omega-Hydroxy-L-Arginine</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03247</drugbank-id>
          <name>Flavin mononucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03904</drugbank-id>
          <name>Urea</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04388</drugbank-id>
          <name>4-Carboxy-4-Aminobutanal</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P00966</uniprot-id>
        <uniprot-id>P04424</uniprot-id>
        <uniprot-id>P31327</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>P04181</uniprot-id>
        <uniprot-id>P30038</uniprot-id>
        <uniprot-id>O43272</uniprot-id>
        <uniprot-id>Q96C36</uniprot-id>
        <uniprot-id>P07814</uniprot-id>
        <uniprot-id>Q7Z4N8</uniprot-id>
        <uniprot-id>Q5T160</uniprot-id>
        <uniprot-id>P50440</uniprot-id>
        <uniprot-id>Q14353</uniprot-id>
        <uniprot-id>P12277</uniprot-id>
        <uniprot-id>P05089</uniprot-id>
        <uniprot-id>P00480</uniprot-id>
        <uniprot-id>Q9Y619</uniprot-id>
        <uniprot-id>P14920</uniprot-id>
        <uniprot-id>P17174</uniprot-id>
        <uniprot-id>P29475</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000005</smpdb-id>
      <name>Pterine Biosynthesis</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01942</drugbank-id>
          <name>Formic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB02385</drugbank-id>
          <name>D-threo-neopterin</name>
        </drug>
        <drug>
          <drugbank-id>DB03896</drugbank-id>
          <name>Triphosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P30793</uniprot-id>
        <uniprot-id>P30047</uniprot-id>
        <uniprot-id>Q03393</uniprot-id>
        <uniprot-id>P35270</uniprot-id>
        <uniprot-id>P15121</uniprot-id>
        <uniprot-id>P16152</uniprot-id>
        <uniprot-id>P00374</uniprot-id>
        <uniprot-id>P09417</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000169</smpdb-id>
      <name>Alkaptonuria</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00126</drugbank-id>
          <name>Ascorbic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>Aspartic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00135</drugbank-id>
          <name>Tyrosine</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB00368</drugbank-id>
          <name>Norepinephrine</name>
        </drug>
        <drug>
          <drugbank-id>DB00668</drugbank-id>
          <name>Epinephrine</name>
        </drug>
        <drug>
          <drugbank-id>DB00988</drugbank-id>
          <name>Dopamine</name>
        </drug>
        <drug>
          <drugbank-id>DB01235</drugbank-id>
          <name>Levodopa</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium cation</name>
        </drug>
        <drug>
          <drugbank-id>DB01592</drugbank-id>
          <name>Iron</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01702</drugbank-id>
          <name>2-(3,4-Dihydroxyphenyl)Acetic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01762</drugbank-id>
          <name>Acetoacetic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01828</drugbank-id>
          <name>Methylamine</name>
        </drug>
        <drug>
          <drugbank-id>DB02232</drugbank-id>
          <name>1,2-Dihydroxybenzene</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03205</drugbank-id>
          <name>Pyrroloquinoline Quinone</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB07718</drugbank-id>
          <name>3-(4-HYDROXY-PHENYL)PYRUVIC ACID</name>
        </drug>
        <drug>
          <drugbank-id>DB08327</drugbank-id>
          <name>2-(3,6-DIHYDROXYPHENYL)ACETIC ACID</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P17735</uniprot-id>
        <uniprot-id>P17174</uniprot-id>
        <uniprot-id>P32754</uniprot-id>
        <uniprot-id>O43708</uniprot-id>
        <uniprot-id>P16930</uniprot-id>
        <uniprot-id>P20711</uniprot-id>
        <uniprot-id>P30838</uniprot-id>
        <uniprot-id>P14679</uniprot-id>
        <uniprot-id>P09172</uniprot-id>
        <uniprot-id>P40126</uniprot-id>
        <uniprot-id>P11086</uniprot-id>
        <uniprot-id>P21397</uniprot-id>
        <uniprot-id>P07327</uniprot-id>
        <uniprot-id>Q93099</uniprot-id>
        <uniprot-id>P14174</uniprot-id>
        <uniprot-id>P19801</uniprot-id>
        <uniprot-id>P21964</uniprot-id>
        <uniprot-id>P46952</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000190</smpdb-id>
      <name>Hawkinsinuria</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00126</drugbank-id>
          <name>Ascorbic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>Aspartic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00135</drugbank-id>
          <name>Tyrosine</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB00368</drugbank-id>
          <name>Norepinephrine</name>
        </drug>
        <drug>
          <drugbank-id>DB00668</drugbank-id>
          <name>Epinephrine</name>
        </drug>
        <drug>
          <drugbank-id>DB00988</drugbank-id>
          <name>Dopamine</name>
        </drug>
        <drug>
          <drugbank-id>DB01235</drugbank-id>
          <name>Levodopa</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium cation</name>
        </drug>
        <drug>
          <drugbank-id>DB01592</drugbank-id>
          <name>Iron</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01702</drugbank-id>
          <name>2-(3,4-Dihydroxyphenyl)Acetic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01762</drugbank-id>
          <name>Acetoacetic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01828</drugbank-id>
          <name>Methylamine</name>
        </drug>
        <drug>
          <drugbank-id>DB02232</drugbank-id>
          <name>1,2-Dihydroxybenzene</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03205</drugbank-id>
          <name>Pyrroloquinoline Quinone</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB07718</drugbank-id>
          <name>3-(4-HYDROXY-PHENYL)PYRUVIC ACID</name>
        </drug>
        <drug>
          <drugbank-id>DB08327</drugbank-id>
          <name>2-(3,6-DIHYDROXYPHENYL)ACETIC ACID</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P17735</uniprot-id>
        <uniprot-id>P17174</uniprot-id>
        <uniprot-id>P32754</uniprot-id>
        <uniprot-id>O43708</uniprot-id>
        <uniprot-id>P16930</uniprot-id>
        <uniprot-id>P20711</uniprot-id>
        <uniprot-id>P30838</uniprot-id>
        <uniprot-id>P14679</uniprot-id>
        <uniprot-id>P09172</uniprot-id>
        <uniprot-id>P40126</uniprot-id>
        <uniprot-id>P11086</uniprot-id>
        <uniprot-id>P21397</uniprot-id>
        <uniprot-id>P07327</uniprot-id>
        <uniprot-id>Q93099</uniprot-id>
        <uniprot-id>P14174</uniprot-id>
        <uniprot-id>P19801</uniprot-id>
        <uniprot-id>P21964</uniprot-id>
        <uniprot-id>P46952</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000207</smpdb-id>
      <name>Prolidase Deficiency (PD)</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00125</drugbank-id>
          <name>L-Arginine</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>Aspartic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00129</drugbank-id>
          <name>Ornithine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00148</drugbank-id>
          <name>Creatine</name>
        </drug>
        <drug>
          <drugbank-id>DB00155</drugbank-id>
          <name>L-Citrulline</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00172</drugbank-id>
          <name>Proline</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB00435</drugbank-id>
          <name>Nitric Oxide</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB02751</drugbank-id>
          <name>Glycocyamine</name>
        </drug>
        <drug>
          <drugbank-id>DB02838</drugbank-id>
          <name>3,4-Dihydro-2h-Pyrrolium-5-Carboxylate</name>
        </drug>
        <drug>
          <drugbank-id>DB03144</drugbank-id>
          <name>N-Omega-Hydroxy-L-Arginine</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03247</drugbank-id>
          <name>Flavin mononucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03904</drugbank-id>
          <name>Urea</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04388</drugbank-id>
          <name>4-Carboxy-4-Aminobutanal</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P00966</uniprot-id>
        <uniprot-id>P04424</uniprot-id>
        <uniprot-id>P31327</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>P04181</uniprot-id>
        <uniprot-id>P30038</uniprot-id>
        <uniprot-id>O43272</uniprot-id>
        <uniprot-id>Q96C36</uniprot-id>
        <uniprot-id>P07814</uniprot-id>
        <uniprot-id>Q7Z4N8</uniprot-id>
        <uniprot-id>Q5T160</uniprot-id>
        <uniprot-id>P50440</uniprot-id>
        <uniprot-id>Q14353</uniprot-id>
        <uniprot-id>P12277</uniprot-id>
        <uniprot-id>P05089</uniprot-id>
        <uniprot-id>P00480</uniprot-id>
        <uniprot-id>Q9Y619</uniprot-id>
        <uniprot-id>P14920</uniprot-id>
        <uniprot-id>P17174</uniprot-id>
        <uniprot-id>P29475</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000208</smpdb-id>
      <name>Prolinemia Type II</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00125</drugbank-id>
          <name>L-Arginine</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>Aspartic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00129</drugbank-id>
          <name>Ornithine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00148</drugbank-id>
          <name>Creatine</name>
        </drug>
        <drug>
          <drugbank-id>DB00155</drugbank-id>
          <name>L-Citrulline</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00172</drugbank-id>
          <name>Proline</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB00435</drugbank-id>
          <name>Nitric Oxide</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB02751</drugbank-id>
          <name>Glycocyamine</name>
        </drug>
        <drug>
          <drugbank-id>DB02838</drugbank-id>
          <name>3,4-Dihydro-2h-Pyrrolium-5-Carboxylate</name>
        </drug>
        <drug>
          <drugbank-id>DB03144</drugbank-id>
          <name>N-Omega-Hydroxy-L-Arginine</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03247</drugbank-id>
          <name>Flavin mononucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03904</drugbank-id>
          <name>Urea</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04388</drugbank-id>
          <name>4-Carboxy-4-Aminobutanal</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P00966</uniprot-id>
        <uniprot-id>P04424</uniprot-id>
        <uniprot-id>P31327</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>P04181</uniprot-id>
        <uniprot-id>P30038</uniprot-id>
        <uniprot-id>O43272</uniprot-id>
        <uniprot-id>Q96C36</uniprot-id>
        <uniprot-id>P07814</uniprot-id>
        <uniprot-id>Q7Z4N8</uniprot-id>
        <uniprot-id>Q5T160</uniprot-id>
        <uniprot-id>P50440</uniprot-id>
        <uniprot-id>Q14353</uniprot-id>
        <uniprot-id>P12277</uniprot-id>
        <uniprot-id>P05089</uniprot-id>
        <uniprot-id>P00480</uniprot-id>
        <uniprot-id>Q9Y619</uniprot-id>
        <uniprot-id>P14920</uniprot-id>
        <uniprot-id>P17174</uniprot-id>
        <uniprot-id>P29475</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000363</smpdb-id>
      <name>Ornithine Aminotransferase Deficiency (OAT Deficiency)</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00125</drugbank-id>
          <name>L-Arginine</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>Aspartic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00129</drugbank-id>
          <name>Ornithine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00148</drugbank-id>
          <name>Creatine</name>
        </drug>
        <drug>
          <drugbank-id>DB00155</drugbank-id>
          <name>L-Citrulline</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00172</drugbank-id>
          <name>Proline</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB00435</drugbank-id>
          <name>Nitric Oxide</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB02751</drugbank-id>
          <name>Glycocyamine</name>
        </drug>
        <drug>
          <drugbank-id>DB02838</drugbank-id>
          <name>3,4-Dihydro-2h-Pyrrolium-5-Carboxylate</name>
        </drug>
        <drug>
          <drugbank-id>DB03144</drugbank-id>
          <name>N-Omega-Hydroxy-L-Arginine</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03247</drugbank-id>
          <name>Flavin mononucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03904</drugbank-id>
          <name>Urea</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04388</drugbank-id>
          <name>4-Carboxy-4-Aminobutanal</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P00966</uniprot-id>
        <uniprot-id>P04424</uniprot-id>
        <uniprot-id>P31327</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>P04181</uniprot-id>
        <uniprot-id>P30038</uniprot-id>
        <uniprot-id>O43272</uniprot-id>
        <uniprot-id>Q96C36</uniprot-id>
        <uniprot-id>P07814</uniprot-id>
        <uniprot-id>Q7Z4N8</uniprot-id>
        <uniprot-id>Q5T160</uniprot-id>
        <uniprot-id>P50440</uniprot-id>
        <uniprot-id>Q14353</uniprot-id>
        <uniprot-id>P12277</uniprot-id>
        <uniprot-id>P05089</uniprot-id>
        <uniprot-id>P00480</uniprot-id>
        <uniprot-id>Q9Y619</uniprot-id>
        <uniprot-id>P14920</uniprot-id>
        <uniprot-id>P17174</uniprot-id>
        <uniprot-id>P29475</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000489</smpdb-id>
      <name>Hyperphenylalaninemia Due to DHPR-Deficiency</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01942</drugbank-id>
          <name>Formic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB02385</drugbank-id>
          <name>D-threo-neopterin</name>
        </drug>
        <drug>
          <drugbank-id>DB03896</drugbank-id>
          <name>Triphosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P30793</uniprot-id>
        <uniprot-id>P30047</uniprot-id>
        <uniprot-id>Q03393</uniprot-id>
        <uniprot-id>P35270</uniprot-id>
        <uniprot-id>P15121</uniprot-id>
        <uniprot-id>P16152</uniprot-id>
        <uniprot-id>P00374</uniprot-id>
        <uniprot-id>P09417</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000490</smpdb-id>
      <name>Segawa Syndrome</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01942</drugbank-id>
          <name>Formic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB02385</drugbank-id>
          <name>D-threo-neopterin</name>
        </drug>
        <drug>
          <drugbank-id>DB03896</drugbank-id>
          <name>Triphosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P30793</uniprot-id>
        <uniprot-id>P30047</uniprot-id>
        <uniprot-id>Q03393</uniprot-id>
        <uniprot-id>P35270</uniprot-id>
        <uniprot-id>P15121</uniprot-id>
        <uniprot-id>P16152</uniprot-id>
        <uniprot-id>P00374</uniprot-id>
        <uniprot-id>P09417</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000491</smpdb-id>
      <name>Sepiapterin Reductase Deficiency</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01942</drugbank-id>
          <name>Formic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB02385</drugbank-id>
          <name>D-threo-neopterin</name>
        </drug>
        <drug>
          <drugbank-id>DB03896</drugbank-id>
          <name>Triphosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P30793</uniprot-id>
        <uniprot-id>P30047</uniprot-id>
        <uniprot-id>Q03393</uniprot-id>
        <uniprot-id>P35270</uniprot-id>
        <uniprot-id>P15121</uniprot-id>
        <uniprot-id>P16152</uniprot-id>
        <uniprot-id>P00374</uniprot-id>
        <uniprot-id>P09417</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000494</smpdb-id>
      <name>Tyrosinemia, Transient, of the Newborn</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00126</drugbank-id>
          <name>Ascorbic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>Aspartic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00135</drugbank-id>
          <name>Tyrosine</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB00368</drugbank-id>
          <name>Norepinephrine</name>
        </drug>
        <drug>
          <drugbank-id>DB00668</drugbank-id>
          <name>Epinephrine</name>
        </drug>
        <drug>
          <drugbank-id>DB00988</drugbank-id>
          <name>Dopamine</name>
        </drug>
        <drug>
          <drugbank-id>DB01235</drugbank-id>
          <name>Levodopa</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium cation</name>
        </drug>
        <drug>
          <drugbank-id>DB01592</drugbank-id>
          <name>Iron</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01702</drugbank-id>
          <name>2-(3,4-Dihydroxyphenyl)Acetic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01762</drugbank-id>
          <name>Acetoacetic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01828</drugbank-id>
          <name>Methylamine</name>
        </drug>
        <drug>
          <drugbank-id>DB02232</drugbank-id>
          <name>1,2-Dihydroxybenzene</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03205</drugbank-id>
          <name>Pyrroloquinoline Quinone</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB07718</drugbank-id>
          <name>3-(4-HYDROXY-PHENYL)PYRUVIC ACID</name>
        </drug>
        <drug>
          <drugbank-id>DB08327</drugbank-id>
          <name>2-(3,6-DIHYDROXYPHENYL)ACETIC ACID</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P17735</uniprot-id>
        <uniprot-id>P17174</uniprot-id>
        <uniprot-id>P32754</uniprot-id>
        <uniprot-id>O43708</uniprot-id>
        <uniprot-id>P16930</uniprot-id>
        <uniprot-id>P20711</uniprot-id>
        <uniprot-id>P30838</uniprot-id>
        <uniprot-id>P14679</uniprot-id>
        <uniprot-id>P09172</uniprot-id>
        <uniprot-id>P40126</uniprot-id>
        <uniprot-id>P11086</uniprot-id>
        <uniprot-id>P21397</uniprot-id>
        <uniprot-id>P07327</uniprot-id>
        <uniprot-id>Q93099</uniprot-id>
        <uniprot-id>P14174</uniprot-id>
        <uniprot-id>P19801</uniprot-id>
        <uniprot-id>P21964</uniprot-id>
        <uniprot-id>P46952</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000498</smpdb-id>
      <name>Dopamine beta-Hydroxylase Deficiency</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00126</drugbank-id>
          <name>Ascorbic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>Aspartic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00135</drugbank-id>
          <name>Tyrosine</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB00368</drugbank-id>
          <name>Norepinephrine</name>
        </drug>
        <drug>
          <drugbank-id>DB00668</drugbank-id>
          <name>Epinephrine</name>
        </drug>
        <drug>
          <drugbank-id>DB00988</drugbank-id>
          <name>Dopamine</name>
        </drug>
        <drug>
          <drugbank-id>DB01235</drugbank-id>
          <name>Levodopa</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium cation</name>
        </drug>
        <drug>
          <drugbank-id>DB01592</drugbank-id>
          <name>Iron</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01702</drugbank-id>
          <name>2-(3,4-Dihydroxyphenyl)Acetic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01762</drugbank-id>
          <name>Acetoacetic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01828</drugbank-id>
          <name>Methylamine</name>
        </drug>
        <drug>
          <drugbank-id>DB02232</drugbank-id>
          <name>1,2-Dihydroxybenzene</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03205</drugbank-id>
          <name>Pyrroloquinoline Quinone</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB07718</drugbank-id>
          <name>3-(4-HYDROXY-PHENYL)PYRUVIC ACID</name>
        </drug>
        <drug>
          <drugbank-id>DB08327</drugbank-id>
          <name>2-(3,6-DIHYDROXYPHENYL)ACETIC ACID</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P17735</uniprot-id>
        <uniprot-id>P17174</uniprot-id>
        <uniprot-id>P32754</uniprot-id>
        <uniprot-id>O43708</uniprot-id>
        <uniprot-id>P16930</uniprot-id>
        <uniprot-id>P20711</uniprot-id>
        <uniprot-id>P30838</uniprot-id>
        <uniprot-id>P14679</uniprot-id>
        <uniprot-id>P09172</uniprot-id>
        <uniprot-id>P40126</uniprot-id>
        <uniprot-id>P11086</uniprot-id>
        <uniprot-id>P21397</uniprot-id>
        <uniprot-id>P07327</uniprot-id>
        <uniprot-id>Q93099</uniprot-id>
        <uniprot-id>P14174</uniprot-id>
        <uniprot-id>P19801</uniprot-id>
        <uniprot-id>P21964</uniprot-id>
        <uniprot-id>P46952</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000506</smpdb-id>
      <name>Hyperornithinemia-Hyperammonemia-Homocitrullinuria [HHH-syndrome]</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00125</drugbank-id>
          <name>L-Arginine</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>Aspartic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00129</drugbank-id>
          <name>Ornithine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00148</drugbank-id>
          <name>Creatine</name>
        </drug>
        <drug>
          <drugbank-id>DB00155</drugbank-id>
          <name>L-Citrulline</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00172</drugbank-id>
          <name>Proline</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB00435</drugbank-id>
          <name>Nitric Oxide</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB02751</drugbank-id>
          <name>Glycocyamine</name>
        </drug>
        <drug>
          <drugbank-id>DB02838</drugbank-id>
          <name>3,4-Dihydro-2h-Pyrrolium-5-Carboxylate</name>
        </drug>
        <drug>
          <drugbank-id>DB03144</drugbank-id>
          <name>N-Omega-Hydroxy-L-Arginine</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03247</drugbank-id>
          <name>Flavin mononucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03904</drugbank-id>
          <name>Urea</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04388</drugbank-id>
          <name>4-Carboxy-4-Aminobutanal</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P00966</uniprot-id>
        <uniprot-id>P04424</uniprot-id>
        <uniprot-id>P31327</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>P04181</uniprot-id>
        <uniprot-id>P30038</uniprot-id>
        <uniprot-id>O43272</uniprot-id>
        <uniprot-id>Q96C36</uniprot-id>
        <uniprot-id>P07814</uniprot-id>
        <uniprot-id>Q7Z4N8</uniprot-id>
        <uniprot-id>Q5T160</uniprot-id>
        <uniprot-id>P50440</uniprot-id>
        <uniprot-id>Q14353</uniprot-id>
        <uniprot-id>P12277</uniprot-id>
        <uniprot-id>P05089</uniprot-id>
        <uniprot-id>P00480</uniprot-id>
        <uniprot-id>Q9Y619</uniprot-id>
        <uniprot-id>P14920</uniprot-id>
        <uniprot-id>P17174</uniprot-id>
        <uniprot-id>P29475</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000533</smpdb-id>
      <name>Monoamine Oxidase-A Deficiency (MAO-A)</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00126</drugbank-id>
          <name>Ascorbic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>Aspartic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00135</drugbank-id>
          <name>Tyrosine</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB00368</drugbank-id>
          <name>Norepinephrine</name>
        </drug>
        <drug>
          <drugbank-id>DB00668</drugbank-id>
          <name>Epinephrine</name>
        </drug>
        <drug>
          <drugbank-id>DB00988</drugbank-id>
          <name>Dopamine</name>
        </drug>
        <drug>
          <drugbank-id>DB01235</drugbank-id>
          <name>Levodopa</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium cation</name>
        </drug>
        <drug>
          <drugbank-id>DB01592</drugbank-id>
          <name>Iron</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01702</drugbank-id>
          <name>2-(3,4-Dihydroxyphenyl)Acetic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01762</drugbank-id>
          <name>Acetoacetic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01828</drugbank-id>
          <name>Methylamine</name>
        </drug>
        <drug>
          <drugbank-id>DB02232</drugbank-id>
          <name>1,2-Dihydroxybenzene</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03205</drugbank-id>
          <name>Pyrroloquinoline Quinone</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB07718</drugbank-id>
          <name>3-(4-HYDROXY-PHENYL)PYRUVIC ACID</name>
        </drug>
        <drug>
          <drugbank-id>DB08327</drugbank-id>
          <name>2-(3,6-DIHYDROXYPHENYL)ACETIC ACID</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P17735</uniprot-id>
        <uniprot-id>P17174</uniprot-id>
        <uniprot-id>P32754</uniprot-id>
        <uniprot-id>O43708</uniprot-id>
        <uniprot-id>P16930</uniprot-id>
        <uniprot-id>P20711</uniprot-id>
        <uniprot-id>P30838</uniprot-id>
        <uniprot-id>P14679</uniprot-id>
        <uniprot-id>P09172</uniprot-id>
        <uniprot-id>P40126</uniprot-id>
        <uniprot-id>P11086</uniprot-id>
        <uniprot-id>P21397</uniprot-id>
        <uniprot-id>P07327</uniprot-id>
        <uniprot-id>Q93099</uniprot-id>
        <uniprot-id>P14174</uniprot-id>
        <uniprot-id>P19801</uniprot-id>
        <uniprot-id>P21964</uniprot-id>
        <uniprot-id>P46952</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0063777</smpdb-id>
      <name>Nitric Oxide Signaling Pathway</name>
      <category>signaling</category>
      <drugs>
        <drug>
          <drugbank-id>DB00125</drugbank-id>
          <name>L-Arginine</name>
        </drug>
        <drug>
          <drugbank-id>DB00155</drugbank-id>
          <name>L-Citrulline</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB00435</drugbank-id>
          <name>Nitric Oxide</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03247</drugbank-id>
          <name>Flavin mononucleotide</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>Q05586</uniprot-id>
        <uniprot-id>Q12879</uniprot-id>
        <uniprot-id>Q8TCU5</uniprot-id>
        <uniprot-id>P78352</uniprot-id>
        <uniprot-id>P29475</uniprot-id>
        <uniprot-id>P62158</uniprot-id>
        <uniprot-id>Q08209</uniprot-id>
        <uniprot-id>P17252</uniprot-id>
        <uniprot-id>P22694</uniprot-id>
      </enzymes>
    </pathway>
  </pathways>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets>
    <target position="1">
      <id>BE0000753</id>
      <name>Phenylalanine-4-hydroxylase</name>
      <organism>Humans</organism>
      <actions>
        <action>cofactor</action>
      </actions>
      <references>
        <articles>
          <article>
            <ref-id>A4679</ref-id>
            <pubmed-id>10089284</pubmed-id>
            <citation>Zekanowski C, Nowacka M, Sendecka E, Sowik M, Cabalska B, Bal J: Identification of Mutations Causing 6-Pyruvoyl- Tetrahydrobiopterin Synthase Deficiency in Polish Patients With Variant Hyperphenylalaninemia. Mol Diagn. 1998 Dec;3(4):237-239.</citation>
          </article>
          <article>
            <ref-id>A4680</ref-id>
            <pubmed-id>10839989</pubmed-id>
            <citation>Werner ER, Habisch HJ, Gorren AC, Schmidt K, Canevari L, Werner-Felmayer G, Mayer B: Contrasting effects of N5-substituted tetrahydrobiopterin derivatives on phenylalanine hydroxylase, dihydropteridine reductase and nitric oxide synthase. Biochem J. 2000 Jun 15;348 Pt 3:579-83.</citation>
          </article>
          <article>
            <ref-id>A4681</ref-id>
            <pubmed-id>10872454</pubmed-id>
            <citation>Fitzpatrick PF: Tetrahydropterin-dependent amino acid hydroxylases. Annu Rev Biochem. 1999;68:355-81.</citation>
          </article>
          <article>
            <ref-id>A4682</ref-id>
            <pubmed-id>10924272</pubmed-id>
            <citation>Ayling JE, Bailey SW, Boerth SR, Giugliani R, Braegger CP, Thony B, Blau N: Hyperphenylalaninemia and 7-pterin excretion associated with mutations in 4a-hydroxy-tetrahydrobiopterin dehydratase/DCoH: analysis of enzyme activity in intestinal biopsies. Mol Genet Metab. 2000 Jul;70(3):179-88.</citation>
          </article>
          <article>
            <ref-id>A4683</ref-id>
            <pubmed-id>11163771</pubmed-id>
            <citation>Jennings IG, Teh T, Kobe B: Essential role of the N-terminal autoregulatory sequence in the regulation of phenylalanine hydroxylase. FEBS Lett. 2001 Jan 19;488(3):196-200.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>yes</known-action>
      <polypeptide id="P00439" source="Swiss-Prot">
        <name>Phenylalanine-4-hydroxylase</name>
        <general-function>Phenylalanine 4-monooxygenase activity</general-function>
        <specific-function/>
        <gene-name>PAH</gene-name>
        <locus>12q22-q24.2</locus>
        <cellular-location/>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>6.57</theoretical-pi>
        <molecular-weight>51861.565</molecular-weight>
        <chromosome-location>12</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:8582</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>PAH</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>K03020</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>189937</identifier>
          </external-identifier>
          <external-identifier>
            <resource>Guide to Pharmacology</resource>
            <identifier>1240</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P00439</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>PH4H_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>1.14.16.1</synonym>
          <synonym>PAH</synonym>
          <synonym>Phe-4-monooxygenase</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0016196|Phenylalanine-4-hydroxylase
MSTAVLENPGLGRKLSDFGQETSYIEDNCNQNGAISLIFSLKEEVGALAKVLRLFEENDV
NLTHIESRPSRLKKDEYEFFTHLDKRSLPALTNIIKILRHDIGATVHELSRDKKKDTVPW
FPRTIQELDRFANQILSYGAELDADHPGFKDPVYRARRKQFADIAYNYRHGQPIPRVEYM
EEEKKTWGTVFKTLKSLYKTHACYEYNHIFPLLEKYCGFHEDNIPQLEDVSQFLQTCTGF
RLRPVAGLLSSRDFLGGLAFRVFHCTQYIRHGSKPMYTPEPDICHELLGHVPLFSDRSFA
QFSQEIGLASLGAPDEYIEKLATIYWFTVEFGLCKQGDSIKAYGAGLLSSFGELQYCLSE
KPKLLPLELEKTAIQNYTVTEFQPLYYVAESFNDAKEKVRNFAATIPRPFSVRYDPYTQR
IEVLDNTQQLKILADSINSEIGILCSALQKIK</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0016197|Phenylalanine-4-hydroxylase (PAH)
ATGTCCACTGCGGTCCTGGAAAACCCAGGCTTGGGCAGGAAACTCTCTGACTTTGGACAG
GAAACAAGCTATATTGAAGACAACTGCAATCAAAATGGTGCCATATCACTGATCTTCTCA
CTCAAAGAAGAAGTTGGTGCATTGGCCAAAGTATTGCGCTTATTTGAGGAGAATGATGTA
AACCTGACCCACATTGAATCTAGACCTTCTCGTTTAAAGAAAGATGAGTATGAATTTTTC
ACCCATTTGGATAAACGTAGCCTGCCTGCTCTGACAAACATCATCAAGATCTTGAGGCAT
GACATTGGTGCCACTGTCCATGAGCTTTCACGAGATAAGAAGAAAGACACAGTGCCCTGG
TTCCCAAGAACCATTCAAGAGCTGGACAGATTTGCCAATCAGATTCTCAGCTATGGAGCG
GAACTGGATGCTGACCACCCTGGTTTTAAAGATCCTGTGTACCGTGCAAGACGGAAGCAG
TTTGCTGACATTGCCTACAACTACCGCCATGGGCAGCCCATCCCTCGAGTGGAATACATG
GAGGAAGAAAAGAAAACATGGGGCACAGTGTTCAAGACTCTGAAGTCCTTGTATAAAACC
CATGCTTGCTATGAGTACAATCACATTTTTCCACTTCTTGAAAAGTACTGTGGCTTCCAT
GAAGATAACATTCCCCAGCTGGAAGACGTTTCTCAATTCCTGCAGACTTGCACTGGTTTC
CGCCTCCGACCTGTGGCTGGCCTGCTTTCCTCTCGGGATTTCTTGGGTGGCCTGGCCTTC
CGAGTCTTCCACTGCACACAGTACATCAGACATGGATCCAAGCCCATGTATACCCCCGAA
CCTGACATCTGCCATGAGCTGTTGGGACATGTGCCCTTGTTTTCAGATCGCAGCTTTGCC
CAGTTTTCCCAGGAAATTGGCCTTGCCTCTCTGGGTGCACCTGATGAATACATTGAAAAG
CTCGCCACAATTTACTGGTTTACTGTGGAGTTTGGGCTCTGCAAACAAGGAGACTCCATA
AAGGCATATGGTGCTGGGCTCCTGTCATCCTTTGGTGAATTACAGTACTGCTTATCAGAG
AAGCCAAAGCTTCTCCCCCTGGAGCTGGAGAAGACAGCCATCCAAAATTACACTGTCACG
GAGTTCCAGCCCCTGTATTACGTGGCAGAGAGTTTTAATGATGCCAAGGAGAAAGTAAGG
AACTTTGCTGCCACAATACCTCGGCCCTTCTCAGTTCGCTACGACCCATACACCCAAAGG
ATTGAGGTCTTGGACAATACCCAGCAGCTTAAGATTTTGGCTGATTCCATTAACAGTGAA
ATTGGAATCCTTTGCAGTGCCCTCCAGAAAATAAAGTAA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF01842</identifier>
            <name>ACT</name>
          </pfam>
          <pfam>
            <identifier>PF00351</identifier>
            <name>Biopterin_H</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cytosol</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>extracellular exosome</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>amino acid binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>cofactor binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>iron ion binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>phenylalanine 4-monooxygenase activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>catecholamine biosynthetic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular amino acid biosynthetic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular nitrogen compound metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>L-phenylalanine catabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>neurotransmitter biosynthetic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>protein hydroxylation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>small molecule metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>tetrahydrobiopterin metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>tyrosine biosynthetic process</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target position="2">
      <id>BE0000263</id>
      <name>Nitric oxide synthase, endothelial</name>
      <organism>Humans</organism>
      <actions>
        <action>cofactor</action>
      </actions>
      <references>
        <articles>
          <article>
            <ref-id>A10426</ref-id>
            <pubmed-id>10075731</pubmed-id>
            <citation>Heller R, Munscher-Paulig F, Grabner R, Till U: L-Ascorbic acid potentiates nitric oxide synthesis in endothelial cells. J Biol Chem. 1999 Mar 19;274(12):8254-60.</citation>
          </article>
          <article>
            <ref-id>A10427</ref-id>
            <pubmed-id>10749876</pubmed-id>
            <citation>Huang A, Vita JA, Venema RC, Keaney JF Jr: Ascorbic acid enhances endothelial nitric-oxide synthase activity by increasing intracellular tetrahydrobiopterin. J Biol Chem. 2000 Jun 9;275(23):17399-406.</citation>
          </article>
          <article>
            <ref-id>A10428</ref-id>
            <pubmed-id>10924132</pubmed-id>
            <citation>Berka V, Tsai AL: Characterization of interactions among the heme center, tetrahydrobiopterin, and L-arginine binding sites of ferric eNOS using imidazole, cyanide, and nitric oxide as probes. Biochemistry. 2000 Aug 8;39(31):9373-83.</citation>
          </article>
          <article>
            <ref-id>A10429</ref-id>
            <pubmed-id>10995244</pubmed-id>
            <citation>Gorren AC, Bec N, Schrammel A, Werner ER, Lange R, Mayer B: Low-temperature optical absorption spectra suggest a redox role for tetrahydrobiopterin in both steps of nitric oxide synthase catalysis. Biochemistry. 2000 Sep 26;39(38):11763-70.</citation>
          </article>
          <article>
            <ref-id>A10430</ref-id>
            <pubmed-id>11009561</pubmed-id>
            <citation>Shinozaki K, Nishio Y, Okamura T, Yoshida Y, Maegawa H, Kojima H, Masada M, Toda N, Kikkawa R, Kashiwagi A: Oral administration of tetrahydrobiopterin prevents endothelial dysfunction and vascular oxidative stress in the aortas of insulin-resistant rats. Circ Res. 2000 Sep 29;87(7):566-73.</citation>
          </article>
          <article>
            <ref-id>A10431</ref-id>
            <pubmed-id>12003347</pubmed-id>
            <citation>Gorren AC, Mayer B: Tetrahydrobiopterin in nitric oxide synthesis: a novel biological role for pteridines. Curr Drug Metab. 2002 Apr;3(2):133-57.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>yes</known-action>
      <polypeptide id="P29474" source="Swiss-Prot">
        <name>Nitric oxide synthase, endothelial</name>
        <general-function>Tetrahydrobiopterin binding</general-function>
        <specific-function>Produces nitric oxide (NO) which is implicated in vascular smooth muscle relaxation through a cGMP-mediated signal transduction pathway. NO mediates vascular endothelial growth factor (VEGF)-induced angiogenesis in coronary vessels and promotes blood clotting through the activation of platelets.Isoform eNOS13C: Lacks eNOS activity, dominant-negative form that may down-regulate eNOS activity by forming heterodimers with isoform 1.</specific-function>
        <gene-name>NOS3</gene-name>
        <locus>7q36</locus>
        <cellular-location>Cell membrane</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>7.27</theoretical-pi>
        <molecular-weight>133287.62</molecular-weight>
        <chromosome-location>7</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:7876</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>NOS3</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>M93718</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>189212</identifier>
          </external-identifier>
          <external-identifier>
            <resource>Guide to Pharmacology</resource>
            <identifier>1249</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P29474</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>NOS3_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>1.14.13.39</synonym>
          <synonym>cNOS</synonym>
          <synonym>Constitutive NOS</synonym>
          <synonym>EC-NOS</synonym>
          <synonym>Endothelial NOS</synonym>
          <synonym>eNOS</synonym>
          <synonym>NOS type III</synonym>
          <synonym>NOSIII</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0036981|Nitric oxide synthase, endothelial
MGNLKSVAQEPGPPCGLGLGLGLGLCGKQGPATPAPEPSRAPASLLPPAPEHSPPSSPLT
QPPEGPKFPRVKNWEVGSITYDTLSAQAQQDGPCTPRRCLGSLVFPRKLQGRPSPGPPAP
EQLLSQARDFINQYYSSIKRSGSQAHEQRLQEVEAEVAATGTYQLRESELVFGAKQAWRN
APRCVGRIQWGKLQVFDARDCRSAQEMFTYICNHIKYATNRGNLRSAITVFPQRCPGRGD
FRIWNSQLVRYAGYRQQDGSVRGDPANVEITELCIQHGWTPGNGRFDVLPLLLQAPDEPP
ELFLLPPELVLEVPLEHPTLEWFAALGLRWYALPAVSNMLLEIGGLEFPAAPFSGWYMST
EIGTRNLCDPHRYNILEDVAVCMDLDTRTTSSLWKDKAAVEINVAVLHSYQLAKVTIVDH
HAATASFMKHLENEQKARGGCPADWAWIVPPISGSLTPVFHQEMVNYFLSPAFRYQPDPW
KGSAAKGTGITRKKTFKEVANAVKISASLMGTVMAKRVKATILYGSETGRAQSYAQQLGR
LFRKAFDPRVLCMDEYDVVSLEHETLVLVVTSTFGNGDPPENGESFAAALMEMSGPYNSS
PRPEQHKSYKIRFNSISCSDPLVSSWRRKRKESSNTDSAGALGTLRFCVFGLGSRAYPHF
CAFARAVDTRLEELGGERLLQLGQGDELCGQEEAFRGWAQAAFQAACETFCVGEDAKAAA
RDIFSPKRSWKRQRYRLSAQAEGLQLLPGLIHVHRRKMFQATIRSVENLQSSKSTRATIL
VRLDTGGQEGLQYQPGDHIGVCPPNRPGLVEALLSRVEDPPAPTEPVAVEQLEKGSPGGP
PPGWVRDPRLPPCTLRQALTFFLDITSPPSPQLLRLLSTLAEEPREQQELEALSQDPRRY
EEWKWFRCPTLLEVLEQFPSVALPAPLLLTQLPLLQPRYYSVSSAPSTHPGEIHLTVAVL
AYRTQDGLGPLHYGVCSTWLSQLKPGDPVPCFIRGAPSFRLPPDPSLPCILVGPGTGIAP
FRGFWQERLHDIESKGLQPTPMTLVFGCRCSQLDHLYRDEVQNAQQRGVFGRVLTAFSRE
PDNPKTYVQDILRTELAAEVHRVLCLERGHMFVCGDVTMATNVLQTVQRILATEGDMELD
EAGDVIGVLRDQQRYHEDIFGLTLRTQEVTSRIRTQSFSLQERQLRGAVPWAFDPPGSDT
NSP</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0010225|Nitric oxide synthase, endothelial (NOS3)
ATGGGCAACTTGAAGAGCGTGGCCCAGGAGCCTGGGCCACCCTGCGGCCTGGGGCTGGGG
CTGGGCCTTGGGCTGTGCGGCAAGCAGGGCCCAGCCACCCCGGCCCCTGAGCCCAGCCGG
GCCCCAGCATCCCTACTCCCACCAGCGCCAGAACACAGCCCCCCGAGCTCCCCGCTAACC
CAGCCCCCAGAGGGGCCCAAGTTCCCTCGTGTGAAGAACTGGGAGGTGGGGAGCATCACC
TATGACACCCTCAGCGCCCAGGCGCAGCAGGATGGGCCCTGCACCCCAAGACGCTGCCTG
GGCTCCCTGGTATTTCCACGGAAACTACAGGGCCGGCCCTCCCCCGGCCCCCCGGCCCCT
GAGCAGCTGCTGAGTCAGGCCCGGGACTTCATCAACCAGTACTACAGCTCCATTAAGAGG
AGCGGCTCCCAGGCCCACGAACAGCGGCTTCAAGAGGTGGAAGCCGAGGTGGCAGCCACA
GGCACCTACCAGCTTAGGGAGAGCGAGCTGGTGTTCGGGGCTAAGCAGGCCTGGCGCAAC
GCTCCCCGCTGCGTGGGCCGGATCCAGTGGGGGAAGCTGCAGGTGTTCGATGCCCGGGAC
TGCAGGTCTGCACAGGAAATGTTCACCTACATCTGCAACCACATCAAGTATGCCACCAAC
CGGGGCAACCTTCGCTCGGCCATCACAGTGTTCCCGCAGCGCTGCCCTGGCCGAGGAGAC
TTCCGAATCTGGAACAGCCAGCTGGTGCGCTACGCGGGCTACCGGCAGCAGGATGGCTCT
GTGCGGGGGGACCCAGCCAACGTGGAGATCACCGAGCTCTGCATTCAGCACGGCTGGACC
CCAGGAAACGGTCGCTTCGACGTGCTGCCCCTGCTGCTGCAGGCCCCAGATGATCCCCCA
GAACTCTTCCTTCTGCCCCCCGAGCTGGTCCTTGAGGTGCCCCTGGAGCACCCCACGCTG
GAGTGGTTTGCAGCCCTGGGCCTGCGCTGGTACGCCCTCCCGGCAGTGTCCAACATGCTG
CTGGAAATTGGGGGCCTGGAGTTCCCCGCAGCCCCCTTCAGTGGCTGGTACATGAGCACT
GAGATCGGCACGAGGAACCTGTGTGACCCTCACCGCTACAACATCCTGGAGGATGTGGCT
GTCTGCATGGACCTGGATACCCGGACCACCTCGTCCCTGTGGAAAGACAAGGCAGCAGTG
GAAATCAACGTGGCCGTGCTGCACAGTTACCAGCTAGCCAAAGTCACCATCGTGGACCAC
CACGCCGCCACGGCCTCTTTCATGAAGCACCTGGAGAATGAGCAGAAGGCCAGGGGGGGC
TGCCCTGCAGACTGGGCCTGGATCGTGCCCCCCATCTCGGGCAGCCTCACTCCTGTTTTC
CATCAGGAGATGGTCAACTATTTCCTGTCCCCGGCCTTCCGCTACCAGCCAGACCCCTGG
AAGGGGAGTGCCGCCAAGGGCACCGGCATCACCAGGAAGAAGACCTTTAAAGAAGTGGCC
AACGCCGTGAAGATCTCCGCCTCGCTCATGGGCACGGTGATGGCGAAGCGAGTGAAGGCG
ACAATCCTGTATGGCTCCGAGACCGGCCGGGCCCAGAGCTACGCACAGCAGCTGGGGAGA
CTCTTCCGGAAGGCTTTTGATCCCCGGGTCCTGTGTATGGATGAGTATGACGTGGTGTCC
CTCGAACACGAGACGCTGGTGCTGGTGGTAACCAGCACATTTGGGAATGGGGATCCCCCG
GAGAATGGAGAGAGCTTTGCAGCTGCCCTGATGGAGATGTCCGGCCCCTACAACAGCTCC
CCTCGGCCGGAACAGCACAAGAGTTATAAGATCCGCTTCAACAGCATCTCCTGCTCAGAC
CCACTGGTGTCCTCTTGGCGGCGGAAGAGGAAGGAGTCCAGTAACACAGACAGTGCAGGG
GCCCTGGGCACCCTCAGGTTCTGTGTGTTCGGGCTCGGCTCCCGGGCATACCCCCACTTC
TGCGCCTTTGCTCGTGCCGTGGACACACGGCTGGAGGAACTGGGCGGGGAGCGGCTGCTG
CAGCTGGGCCAGGGCGACGAGCTGTGCGGCCAGGAGGAGGCCTTCCGAGGCTGGGCCCAG
GCTGCCTTCCAGGCCGCCTGTGAGACCTTCTGTGTGGGAGAGGATGCCAAGGCCGCCGCC
CGAGACATCTTCAGCCCCAAACGGAGCTGGAAGCGCCAGAGGTACCGGCTGAGCGCCCAG
GCCGAGGGCCTGCAGTTGCTGCCAGGTCTGATCCACGTGCACAGGCGGAAGATGTTCCAG
GCTACAATCCGCTCAGTGGAAAACCTGCAAAGCAGCAAGTCCACGAGGGCCACCATCCTG
GTGCGCCTGGACACCGGAGGCCAGGAGGGGCTGCAGTACCAGCCGGGGGACCACATAGGT
GTCTGCCCGCCCAACCGGCCCGGCCTTGTGGAGGCGCTGCTGAGCCGCGTGGAGGACCCG
CCGGCGCCCACTGAGCCCGTGGCAGTAGAGCAGCTGGAGAAGGGCAGCCCTGGTGGCCCT
CCCCCCGGCTGGGTGCGGGACCCCCGGCTGCCCCCGTGCACGCTGCGCCAGGCTCTCACC
TTCTTCCTGGACATCACCTCCCCACCCAGCCCTCAGCTCTTGCGGCTGCTCAGCACCTTG
GCAGAAGAGCCCAGGGAACAGCAGGAGCTGGAGGCCCTCAGCCAGGATCCCCGACGCTAC
GAGGAGTGGAAGTGGTTCCGCTGCCCCACGCTGCTGGAGGTGCTGGAGCAGTTCCCGTCG
GTGGCGCTGCCTGCCCCACTGCTCCTCACCCAGCTGCCTCTGCTCCAGCCCCGGTACTAC
TCAGTCAGCTCGGCACCCAGCACCCACCCAGGAGAGATCCACCTCACTGTAGCTGTGCTG
GCATACAGGACTCAGGATGGGCTGGGCCCCCTGCACTATGGAGTCTGCTCCACGTGGCTA
AGCCAGCTCAAGCCCGGAGACCCTGTGCCCTGCTTCATCCGGGGGGCTCCCTCCTTCCGG
CTGCCACCCGATCCCAGCTTGCCCTGCATCCTGGTGGGTCCAGGCACTGGCATTGCCCCC
TTCCGGGGATTCTGGCAGGAGCGGCTGCATGACATTGAGAGCAAAGGGCTGCAGCCCACT
CCCATGACTTTGGTGTTCGGCTGCCGATGCTCCCAACTTGACCATCTCTACCGCGACGAG
GTGCAGAACGCCCAGCAGCGCGGGGTGTTTGGCCGAGTCCTCACCGCCTTCTCCCGGGAA
CCTGACAACCCCAAGACCTACGTGCAGGACATCCTGAGGACGGAGCTGGCTGCGGAGGTG
CACCGCGTGCTGTGCCTCGAGCGGGGCCACATGTTTGTCTGCGGCGATGTTACCATGGCA
ACCAACGTCCTGCAGACCGTGCAGCGCATCCTGGCGACGGAGGGCGACATGGAGCTGGAC
GAGGCCGGCGACGTCATCGGCGTGCTGCGGGATCAGCAACGCTACCACGAAGACATTTTC
GGGCTCACGCTGCGCACCCAGGAGGTGACAAGCCGCATACGCACCCAGAGCTTTTCCTTG
CAGGAGCGTCAGTTGCGGGGCGCAGTGCCCTGGGCGTTCGACCCTCCCGGCTCAGACACC
AACAGCCCCTGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00667</identifier>
            <name>FAD_binding_1</name>
          </pfam>
          <pfam>
            <identifier>PF00258</identifier>
            <name>Flavodoxin_1</name>
          </pfam>
          <pfam>
            <identifier>PF00175</identifier>
            <name>NAD_binding_1</name>
          </pfam>
          <pfam>
            <identifier>PF02898</identifier>
            <name>NO_synthase</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>caveola</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>cytoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>cytoskeleton</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>cytosol</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>endocytic vesicle membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>Golgi membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>nucleus</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>actin monomer binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>arginine binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>cadmium ion binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>flavin adenine dinucleotide binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>FMN binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>heme binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>iron ion binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>NADP binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>NADPH-hemoprotein reductase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>nitric-oxide synthase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>tetrahydrobiopterin binding</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>angiogenesis</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>arginine catabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>blood coagulation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>blood vessel remodeling</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>endothelial cell migration</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>in utero embryonic development</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>lipopolysaccharide-mediated signaling pathway</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>lung development</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>mitochondrion organization</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of blood pressure</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of calcium ion transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of cell proliferation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of extrinsic apoptotic signaling pathway via death domain receptors</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of hydrolase activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of muscle hyperplasia</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of platelet activation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of potassium ion transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>nitric oxide biosynthetic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>nitric oxide mediated signal transduction</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>nitric oxide metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>ovulation from ovarian follicle</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>phagosome maturation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of angiogenesis</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of guanylate cyclase activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of vasodilation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>regulation of blood pressure</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>regulation of blood vessel size</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>regulation of nitric-oxide synthase activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>regulation of sodium ion transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>regulation of systemic arterial blood pressure by endothelin</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>regulation of the force of heart contraction by chemical signal</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>removal of superoxide radicals</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to fluid shear stress</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to heat</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>small molecule metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>smooth muscle hyperplasia</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>vascular endothelial growth factor receptor signaling pathway</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target position="3">
      <id>BE0000614</id>
      <name>Tyrosine 3-monooxygenase</name>
      <organism>Humans</organism>
      <actions>
        <action>cofactor</action>
      </actions>
      <references>
        <articles>
          <article>
            <ref-id>A10432</ref-id>
            <pubmed-id>10197775</pubmed-id>
            <citation>Koshimura K, Tanaka J, Murakami Y, Kato Y: Enhancement of neuronal survival by 6R-tetrahydrobiopterin. Neuroscience. 1999 Jan;88(2):561-9.</citation>
          </article>
          <article>
            <ref-id>A10433</ref-id>
            <pubmed-id>10411647</pubmed-id>
            <citation>Flatmark T, Almas B, Knappskog PM, Berge SV, Svebak RM, Chehin R, Muga A, Martinez A: Tyrosine hydroxylase binds tetrahydrobiopterin cofactor with negative cooperativity, as shown by kinetic analyses and surface plasmon resonance detection. Eur J Biochem. 1999 Jun;262(3):840-9.</citation>
          </article>
          <article>
            <ref-id>A10434</ref-id>
            <pubmed-id>10464780</pubmed-id>
            <citation>Ichinose H, Ohye T, Suzuki T, Inagaki H, Nagatsu T: [The relation between metabolism of biopterin and dystonia-parkinsonism]. Nihon Shinkei Seishin Yakurigaku Zasshi. 1999 Apr;19(2):85-9.</citation>
          </article>
          <article>
            <ref-id>A10435</ref-id>
            <pubmed-id>10543618</pubmed-id>
            <citation>Schwarz EJ, Alexander GM, Prockop DJ, Azizi SA: Multipotential marrow stromal cells transduced to produce L-DOPA: engraftment in a rat model of Parkinson disease. Hum Gene Ther. 1999 Oct 10;10(15):2539-49.</citation>
          </article>
          <article>
            <ref-id>A10436</ref-id>
            <pubmed-id>10643998</pubmed-id>
            <citation>Schallreuter KU: A review of recent advances on the regulation of pigmentation in the human epidermis. Cell Mol Biol (Noisy-le-grand). 1999 Nov;45(7):943-9.</citation>
          </article>
          <article>
            <ref-id>A9</ref-id>
            <pubmed-id>11752352</pubmed-id>
            <citation>Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>yes</known-action>
      <polypeptide id="P07101" source="Swiss-Prot">
        <name>Tyrosine 3-monooxygenase</name>
        <general-function>Tyrosine 3-monooxygenase activity</general-function>
        <specific-function>Plays an important role in the physiology of adrenergic neurons.</specific-function>
        <gene-name>TH</gene-name>
        <locus>11p15.5</locus>
        <cellular-location/>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>6.25</theoretical-pi>
        <molecular-weight>58599.545</molecular-weight>
        <chromosome-location>11</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:11782</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>TH</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>Y00414</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>37127</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P07101</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>TY3H_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>1.14.16.2</synonym>
          <synonym>TH</synonym>
          <synonym>TYH</synonym>
          <synonym>Tyrosine 3-hydroxylase</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0037053|Tyrosine 3-monooxygenase
MPTPDATTPQAKGFRRAVSELDAKQAEAIMVRGQGAPGPSLTGSPWPGTAAPAASYTPTP
RSPRFIGRRQSLIEDARKEREAAVAAAAAAVPSEPGDPLEAVAFEEKEGKAVLNLLFSPR
ATKPSALSRAVKVFETFEAKIHHLETRPAQRPRAGGPHLEYFVRLEVRRGDLAALLSGVR
QVSEDVRSPAGPKVPWFPRKVSELDKCHHLVTKFDPDLDLDHPGFSDQVYRQRRKLIAEI
AFQYRHGDPIPRVEYTAEEIATWKEVYTTLKGLYATHACGEHLEAFALLERFSGYREDNI
PQLEDVSRFLKERTGFQLRPVAGLLSARDFLASLAFRVFQCTQYIRHASSPMHSPEPDCC
HELLGHVPMLADRTFAQFSQDIGLASLGASDEEIEKLSTLYWFTVEFGLCKQNGEVKAYG
AGLLSSYGELLHCLSEEPEIRAFDPEAAAVQPYQDQTYQSVYFVSESFSDAKDKLRSYAS
RIQRPFSVKFDPYTLAIDVLDSPQAVRRSLEGVQDELDTLAHALSAIG</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0016153|Tyrosine 3-monooxygenase (TH)
ATGCCCACCCCCGACGCCACCACGCCACAGGCCAAGGGCTTCCGCAGGGCCGTGTCTGAG
CTGGACGCCAAGCAGGCAGAGGCCATCATGTCCCCGCGGTTCATTGGGCGCAGGCAGAGC
CTCATCGAGGACGCCCGCAAGGAGCGGGAGGCGGCGGTGGCAGCAGCGGCCGCTGCAGTC
CCCTCGGAGCCCGGGGACCCCCTGGAGGCTGTGGCCTTTGAGGAGAAGGAGGGGAAGGCC
GTGCTAAACCTGCTCTTCTCCCCGAGGGCCACCAAGCCCTCGGCGCTGTCCCGAGCTGTG
AAGGTGTTTGAGACGTTTGAAGCCAAAATCCACCATCTAGAGACCCGGCCCGCCCAGAGG
CCGCGAGCTGGGGGCCCCCACCTGGAGTACTTCGTGCGCCTCGAGGTGCGCCGAGGGGAC
CTGGCCGCCCTGCTCAGTGGTGTGCGCCAGGTGTCAGAGGACGTGCGCAGCCCCGCGGGG
CCCAAGGTCCCCTGGTTCCCAAGAAAAGTGTCAGAGCTGGACAAGTGTCATCACCTGGTC
ACCAAGTTCGACCCTGACCTGGACTTGGACCACCCGGGCTTCTCGGACCAGGTGTACCGC
CAGCGCAGGAAGCTGATTGCTGAGATCGCCTTCCAGTACAGGCACGGCGACCCGATTCCC
CGTGTGGAGTACACCGCCGAGGAGATTGCCACCTGGAAGGAGGTCTACACCACGCTGAAG
GGCCTCTACGCCACGCACGCCTGCGGGGAGCACCTGGAGGCCTTTGCTTTGCTGGAGCGC
TTCAGCGGCTACCGGGAAGACAATATCCCCCAGCTGGAGGACGTCTCCCGCTTCCTGAAG
GAGCGCACGGGCTTCCAGCTGCGGCCTGTGGCCGGCCTGCTGTCCGCCCGGGACTTCCTG
GCCAGCCTGGCCTTCCGCGTGTTCCAGTGCACCCAGTATATCCGCCACGCGTCCTCGCCC
ATGCACTCCCCTGAGCCGGACTGCTGCCACGAGCTGCTGGGGCACGTGCCCATGCTGGCC
GACCGCACCTTCGCGCAGTTCTCGCAGGACATTGGCCTGGCGTCCCTGGGGGCCTCGGAT
GAGGAAATTGAGAAGCTGTCCACGCTGTACTGGTTCACGGTGGAGTTCGGGCTGTGTAAG
CAGAACGGGGAGGTGAAGGCCTATGGTGCCGGGCTGCTGTCCTCCTACGGGGAGCTCCTG
CACTGCCTGTCTGAGGAGCCTGAGATTCGGGCCTTCGACCCTGAGGCTGCGGCCGTGCAG
CCCTACCAAGACCAGACGTACCAGTCAGTCTACTTCGTGTCTGAGAGCTTCAGTGACGCC
AAGGACAAGCTCAGGAGCTATGCCTCACGCATCCAGCGCCCCTTCTCCGTGAAGTTCGAC
CCGTACACGCTGGCCATCGACGTGCTGGACAGCCCCCAGGCCGTGCGGCGCTCCCTGGAG
GGTGTCCAGGATGAGCTGGACACCCTTGCCCATGCGCTGAGTGCCATTGGCTAG</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00351</identifier>
            <name>Biopterin_H</name>
          </pfam>
          <pfam>
            <identifier>PF12549</identifier>
            <name>TOH_N</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cytoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>cytoplasmic side of plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>cytoplasmic vesicle</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>cytosol</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>dendrite</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>melanosome membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>mitochondrion</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>neuron projection</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>nucleus</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>perikaryon</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>smooth endoplasmic reticulum</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>synaptic vesicle</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>terminal bouton</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>amino acid binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>dopamine binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>enzyme binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>ferric iron binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>ferrous iron binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>oxygen binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>tetrahydrobiopterin binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>tyrosine 3-monooxygenase activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>anatomical structure morphogenesis</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>catecholamine biosynthetic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular nitrogen compound metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular response to drug</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular response to glucose stimulus</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular response to growth factor stimulus</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular response to manganese ion</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular response to nicotine</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cerebral cortex development</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>circadian sleep/wake cycle</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>dopamine biosynthetic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>dopamine biosynthetic process from tyrosine</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>eating behavior</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>embryonic camera-type eye morphogenesis</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>epinephrine biosynthetic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>eye photoreceptor cell development</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>fatty acid metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>glycoside metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>heart development</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>heart morphogenesis</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>isoquinoline alkaloid metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>learning</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>locomotory behavior</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>mating behavior</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>memory</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>multicellular organismal aging</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>neurotransmitter biosynthetic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>norepinephrine biosynthetic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>organ morphogenesis</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>phthalate metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>phytoalexin metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>pigmentation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>regulation of heart contraction</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to amphetamine</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to corticosterone</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to electrical stimulus</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to estradiol</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to ethanol</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to ether</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to herbicide</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to hypoxia</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to immobilization stress</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to isolation stress</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to light stimulus</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to lipopolysaccharide</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to nutrient levels</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to peptide hormone</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to pyrethroid</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to salt stress</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to water deprivation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to zinc ion</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>sensory perception of sound</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>small molecule metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>social behavior</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>sphingolipid metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>synaptic transmission, dopaminergic</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>synaptic vesicle amine transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>terpene metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>visual perception</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target position="4">
      <id>BE0000121</id>
      <name>Tryptophan 5-hydroxylase 1</name>
      <organism>Humans</organism>
      <actions>
        <action>cofactor</action>
      </actions>
      <references>
        <articles>
          <article>
            <ref-id>A10437</ref-id>
            <pubmed-id>10381000</pubmed-id>
            <citation>Chamas F, Serova L, Sabban EL: Tryptophan hydroxylase mRNA levels are elevated by repeated immobilization stress in rat raphe nuclei but not in pineal gland. Neurosci Lett. 1999 Jun 4;267(3):157-60.</citation>
          </article>
          <article>
            <ref-id>A10438</ref-id>
            <pubmed-id>11472242</pubmed-id>
            <citation>Martinez A, Knappskog PM, Haavik J: A structural approach into human tryptophan hydroxylase and its implications for the regulation of serotonin biosynthesis. Curr Med Chem. 2001 Jul;8(9):1077-91.</citation>
          </article>
          <article>
            <ref-id>A10439</ref-id>
            <pubmed-id>12414107</pubmed-id>
            <citation>Ikemoto K, Suzuki T, Ichinose H, Ohye T, Nishimura A, Nishi K, Nagatsu I, Nagatsu T: Localization of sepiapterin reductase in the human brain. Brain Res. 2002 Nov 8;954(2):237-46.</citation>
          </article>
          <article>
            <ref-id>A10440</ref-id>
            <pubmed-id>15223360</pubmed-id>
            <citation>Serova LI, Maharjan S, Huang A, Sun D, Kaley G, Sabban EL: Response of tyrosine hydroxylase and GTP cyclohydrolase I gene expression to estrogen in brain catecholaminergic regions varies with mode of administration. Brain Res. 2004 Jul 23;1015(1-2):1-8.</citation>
          </article>
          <article>
            <ref-id>A10441</ref-id>
            <pubmed-id>2665179</pubmed-id>
            <citation>Haavik J: [From butterflies to neurobiology and the diagnosis of AIDS. The 100th anniversary of the discovery of pteridines]. Tidsskr Nor Laegeforen. 1989 Jun 30;109(19-21):1986-9.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>yes</known-action>
      <polypeptide id="P17752" source="Swiss-Prot">
        <name>Tryptophan 5-hydroxylase 1</name>
        <general-function>Tryptophan 5-monooxygenase activity</general-function>
        <specific-function/>
        <gene-name>TPH1</gene-name>
        <locus>11p15.3-p14</locus>
        <cellular-location/>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>7.23</theoretical-pi>
        <molecular-weight>50984.725</molecular-weight>
        <chromosome-location>11</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:12008</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>TPH1</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>X52836</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>37955</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P17752</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>TPH1_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>1.14.16.4</synonym>
          <synonym>TPH</synonym>
          <synonym>TPRH</synonym>
          <synonym>TRPH</synonym>
          <synonym>Tryptophan 5-monooxygenase 1</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0000242|Tryptophan 5-hydroxylase 1
MIEDNKENKDHSLERGRASLIFSLKNEVGGLIKALKIFQEKHVNLLHIESRKSKRRNSEF
EIFVDCDINREQLNDIFHLLKSHTNVLSVNLPDNFTLKEDGMETVPWFPKKISDLDHCAN
RVLMYGSELDADHPGFKDNVYRKRRKYFADLAMNYKHGDPIPKVEFTEEEIKTWGTVFQE
LNKLYPTHACREYLKNLPLLSKYCGYREDNIPQLEDVSNFLKERTGFSIRPVAGYLSPRD
FLSGLAFRVFHCTQYVRHSSDPFYTPEPDTCHELLGHVPLLAEPSFAQFSQEIGLASLGA
SEEAVQKLATCYFFTVEFGLCKQDGQLRVFGAGLLSSISELKHALSGHAKVKPFDPKITC
KQECLITTFQDVYFVSESFEDAKEKMREFTKTIKRPFGVKYNPYTRSIQILKDTKSITSA
MNELQHDLDVVSDALAKVSRKPSI</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0009948|Tryptophan 5-hydroxylase 1 (TPH1)
ATGATTGAAGACAATAAGGAGAACAAAGACCATTCCTTAGAAAGGGGAAGAGCAAGTCTC
ATTTTTTCCTTAAAGAATGAAGTTGGAGGACTTATAAAAGCCCTGAAAATCTTTCAGGAG
AAGCATGTGAATCTGTTACATATCGAGTCCCGAAAATCAAAAAGAAGAAACTCAGAATTT
GAGATTTTTGTTGACTGTGACATCAACAGAGAACAATTGAATGATATTTTTCATCTGCTG
AAGTCTCATACCAATGTTCTCTCTGTGAATCTACCAGATAATTTTACTTTGAAGGAAGAT
GGTATGGAAACTGTTCCTTGGTTTCCAAAGAAGATTTCTGACCTGGACCATTGTGCCAAC
AGAGTTCTGATGTATGGATCTGAACTAGATGCAGACCATCCTGGCTTCAAAGACAATGTC
TACCGTAAACGTCGAAAGTATTTTGCGGACTTGGCTATGAACTATAAACATGGAGACCCC
ATTCCAAAGGTTGAATTCACTGAAGAGGAGATTAAGACCTGGGGAACCGTATTCCAAGAG
CTCAACAAACTCTACCCAACCCATGCTTGCAGAGAGTATCTCAAAAACTTACCTTTGCTT
TCTAAATATTGTGGATATCGGGAGGATAATATCCCACAATTGGAAGATGTCTCCAACTTT
TTAAAAGAGCGTACAGGTTTTTCCATCCGTCCTGTGGCTGGTTACTTATCACCAAGAGAT
TTCTTATCAGGTTTAGCCTTTCGAGTTTTTCACTGCACTCAATATGTGAGACACAGTTCA
GATCCCTTCTATACCCCAGAGCCAGATACCTGCCATGAACTCTTAGGTCATGTCCCGCTT
TTGGCTGAACCTAGTTTTGCCCAATTCTCCCAAGAAATTGGCTTGGCTTCTCTTGGCGCT
TCAGAGGAGGCTGTTCAAAAACTGGCAACGTGCTACTTTTTCACTGTGGAGTTTGGTCTA
TGTAAACAAGATGGACAGCTAAGAGTCTTTGGTGCTGGCTTACTTTCTTCTATCAGTGAA
CTCAAACATGCACTTTCTGGACATGCCAAAGTAAAGCCCTTTGATCCCAAGATTACCTGC
AAACAGGAATGTCTTATCACAACTTTTCAAGATGTCTACTTTGTATCTGAAAGTTTTGAA
GATGCAAAGGAGAAGATGAGAGAATTTACCAAAACAATTAAGCGTCCATTTGGAGTGAAG
TATAATCCATATACACGGAGTATTCAGATCCTGAAAGACACCAAGAGCATAACCAGTGCC
ATGAATGAGCTGCAGCATGATCTCGATGTTGTCAGTGATGCCCTTGCTAAGGTCAGCAGG
AAGCCGAGTATCTAA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00351</identifier>
            <name>Biopterin_H</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cytosol</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>neuron projection</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>amino acid binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>iron ion binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>tryptophan 5-monooxygenase activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>aromatic amino acid family metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>bone remodeling</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular nitrogen compound metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>circadian rhythm</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>indolalkylamine biosynthetic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>mammary gland alveolus development</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of ossification</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of fat cell differentiation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to immobilization stress</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>serotonin biosynthetic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>small molecule metabolic process</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
  </targets>
  <enzymes>
    <enzyme position="5">
      <id>BE0000262</id>
      <name>Prostaglandin G/H synthase 2</name>
      <organism>Humans</organism>
      <actions>
        <action>inducer</action>
      </actions>
      <references>
        <articles>
          <article>
            <ref-id>A17816</ref-id>
            <pubmed-id>17560944</pubmed-id>
            <citation>Chae SW, Bang YJ, Kim KM, Lee KY, Kang BY, Kim EM, Inoue H, Hwang O, Choi HJ: Role of cyclooxygenase-2 in tetrahydrobiopterin-induced dopamine oxidation. Biochem Biophys Res Commun. 2007 Aug 3;359(3):735-41. Epub 2007 Jun 4.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P35354" source="Swiss-Prot">
        <name>Prostaglandin G/H synthase 2</name>
        <general-function>Prostaglandin-endoperoxide synthase activity</general-function>
        <specific-function>Converts arachidonate to prostaglandin H2 (PGH2), a committed step in prostanoid synthesis. Constitutively expressed in some tissues in physiological conditions, such as the endothelium, kidney and brain, and in pathological conditions, such as in cancer. PTGS2 is responsible for production of inflammatory prostaglandins. Up-regulation of PTGS2 is also associated with increased cell adhesion, phenotypic changes, resistance to apoptosis and tumor angiogenesis. In cancer cells, PTGS2 is a key step in the production of prostaglandin E2 (PGE2), which plays important roles in modulating motility, proliferation and resistance to apoptosis.</specific-function>
        <gene-name>PTGS2</gene-name>
        <locus>1q25.2-q25.3</locus>
        <cellular-location>Microsome membrane</cellular-location>
        <transmembrane-regions/>
        <signal-regions>1-17</signal-regions>
        <theoretical-pi>7.41</theoretical-pi>
        <molecular-weight>68995.625</molecular-weight>
        <chromosome-location>1</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:9605</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>PTGS2</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>L15326</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>291988</identifier>
          </external-identifier>
          <external-identifier>
            <resource>Guide to Pharmacology</resource>
            <identifier>1376</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P35354</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>PGH2_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>1.14.99.1</synonym>
          <synonym>COX-2</synonym>
          <synonym>COX2</synonym>
          <synonym>Cyclooxygenase-2</synonym>
          <synonym>PGH synthase 2</synonym>
          <synonym>PGHS-2</synonym>
          <synonym>PHS II</synonym>
          <synonym>Prostaglandin H2 synthase 2</synonym>
          <synonym>Prostaglandin-endoperoxide synthase 2</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0021832|Prostaglandin G/H synthase 2
MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFL
TRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADY
GYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGS
NMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKY
QIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCD
VLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQ
NRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRV
AGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEAL
YGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEV
GFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKER
STEL</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0021833|Prostaglandin G/H synthase 2 (PTGS2)
ATGCTCGCCCGCGCCCTGCTGCTGTGCGCGGTCCTGGCGCTCAGCCATACAGCAAATCCT
TGCTGTTCCCACCCATGTCAAAACCGAGGTGTATGTATGAGTGTGGGATTTGACCAGTAT
AAGTGCGATTGTACCCGGACAGGATTCTATGGAGAAAACTGCTCAACACCGGAATTTTTG
ACAAGAATAAAATTATTTCTGAAACCCACTCCAAACACAGTGCACTACATACTTACCCAC
TTCAAGGGATTTTGGAACGTTGTGAATAACATTCCCTTCCTTCGAAATGCAATTATGAGT
TATGTGTTGACATCCAGATCACATTTGATTGACAGTCCACCAACTTACAATGCTGACTAT
GGCTACAAAAGCTGGGAAGCCTTCTCTAACCTCTCCTATTATACTAGAGCCCTTCCTCCT
GTGCCTGATGATTGCCCGACTCCCTTGGGTGTCAAAGGTAAAAAGCAGCTTCCTGATTCA
AATGAGATTGTGGAAAAATTGCTTCTAAGAAGAAAGTTCATCCCTGATCCCCAGGGCTCA
AACATGATGTTTGCATTCTTTGCCCAGCACTTCACGCATCAGTTTTTCAAGACAGATCAT
AAGCGAGGGCCAGCTTTCACCAACGGGCTGGGCCATGGGGTGGACTTAAATCATATTTAC
GGTGAAACTCTGGCTAGACAGCGTAAACTGCGCCTTTTCAAGGATGGAAAAATGAAATAT
CAGATAATTGATGGAGAGATGTATCCTCCCACAGTCAAAGATACTCAGGCAGAGATGATC
TACCCTCCTCAAGTCCCTGAGCATCTACGGTTTGCTGTGGGGCAGGAGGTCTTTGGTCTG
GTGCCTGGTCTGATGATGTATGCCACAATCTGGCTGCGGGAACACAACAGAGTATGCGAT
GTGCTTAAACAGGAGCATCCTGAATGGGGTGATGAGCAGTTGTTCCAGACAAGCAGGCTA
ATACTGATAGGAGAGACTATTAAGATTGTGATTGAAGATTATGTGCAACACTTGAGTGGC
TATCACTTCAAACTGAAATTTGACCCAGAACTACTTTTCAACAAACAATTCCAGTACCAA
AATCGTATTGCTGCTGAATTTAACACCCTCTATCACTGGCATCCCCTTCTGCCTGACACC
TTTCAAATTCATGACCAGAAATACAACTATCAACAGTTTATCTACAACAACTCTATATTG
CTGGAACATGGAATTACCCAGTTTGTTGAATCATTCACCAGGCAAATTGCTGGCAGGGTT
GCTGGTGGTAGGAATGTTCCACCCGCAGTACAGAAAGTATCACAGGCTTCCATTGACCAG
AGCAGGCAGATGAAATACCAGTCTTTTAATGAGTACCGCAAACGCTTTATGCTGAAGCCC
TATGAATCATTTGAAGAACTTACAGGAGAAAAGGAAATGTCTGCAGAGTTGGAAGCACTC
TATGGTGACATCGATGCTGTGGAGCTGTATCCTGCCCTTCTGGTAGAAAAGCCTCGGCCA
GATGCCATCTTTGGTGAAACCATGGTAGAAGTTGGAGCACCATTCTCCTTGAAAGGACTT
ATGGGTAATGTTATATGTTCTCCTGCCTACTGGAAGCCAAGCACTTTTGGTGGAGAAGTG
GGTTTTCAAATCATCAACACTGCCTCAATTCAGTCTCTCATCTGCAATAACGTGAAGGGC
TGTCCCTTTACTTCATTCAGTGTTCCAGATCCAGAGCTCATTAAAACAGTCACCATCAAT
GCAAGTTCTTCCCGCTCCGGACTAGATGATATCAATCCCACAGTACTACTAAAAGAACGT
TCGACTGAACTGTAG</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF03098</identifier>
            <name>An_peroxidase</name>
          </pfam>
          <pfam>
            <identifier>PF00008</identifier>
            <name>EGF</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>caveola</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>cytoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>endoplasmic reticulum</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>endoplasmic reticulum lumen</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>endoplasmic reticulum membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>neuron projection</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>nucleus</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>protein complex</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>arachidonate 15-lipoxygenase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>enzyme binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>heme binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>lipid binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>metal ion binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>peroxidase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>prostaglandin-endoperoxide synthase activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>angiogenesis</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>arachidonic acid metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>bone mineralization</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>brown fat cell differentiation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular response to ATP</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular response to fluid shear stress</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular response to hypoxia</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular response to mechanical stimulus</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular response to UV</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cyclooxygenase pathway</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>decidualization</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>embryo implantation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>hair cycle</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>inflammatory response</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>learning</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>lipoxygenase pathway</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>maintenance of blood-brain barrier</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>memory</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>movement of cell or subcellular component</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>NAD metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of calcium ion transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of cell cycle</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of cell proliferation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of smooth muscle contraction</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of synaptic transmission, dopaminergic</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>nicotinamide metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>ovulation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of apoptotic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of brown fat cell differentiation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of cell migration involved in sprouting angiogenesis</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of fever generation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of fibroblast growth factor production</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of NF-kappaB import into nucleus</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of nitric oxide biosynthetic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of platelet-derived growth factor production</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of prostaglandin biosynthetic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of smooth muscle cell proliferation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of smooth muscle contraction</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of synaptic plasticity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of synaptic transmission, glutamatergic</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of transforming growth factor beta production</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of vascular endothelial growth factor production</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of vasoconstriction</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>prostaglandin biosynthetic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>prostaglandin metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>regulation of blood pressure</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>regulation of inflammatory response</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to drug</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to estradiol</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to fatty acid</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to fructose</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to glucocorticoid</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to lipopolysaccharide</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to lithium ion</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to manganese ion</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to oxidative stress</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to tumor necrosis factor</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to vitamin D</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>sensory perception of pain</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>small molecule metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>vitamin metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>water-soluble vitamin metabolic process</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
      <inhibition-strength/>
      <induction-strength>unknown</induction-strength>
    </enzyme>
  </enzymes>
  <carriers/>
  <transporters/>
</drug>